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ABSTRACT

Tabatabaei Ghomi, Hamed. Ph.D., Purdue University, December 2015. Computational
Modelling of Protein Fibrillation with Application to Glucagon. Major Professor: Markus
A. Lill.

A computational method to model the steric zipper of amyloid fibrils (FibPreditor) is
developed. The method generates an ensemble of structures for the steric zipper by a
number of geometric operations and presents the most energetically favorable candidates
as models of steric zipper. The method is shown to successfully reproduce a number of
experimentally determined fibril structures.
FibPredictor is then applied to model the steric zipper of glucagon fibrils. Phosphate ester
derivatives of glucagon are designed based on these models as soluble and stable
prodrugs or active alternatives for glucagon.
A number of penta-peptide chaperones are also designed as excipients to delay glucagon
fibrillation. Although penta-peptides can delay glucagon fibrillation, they are less
effective compared to phosphorylation of glucagon.

1

CHAPTER 1. INTRODUCTION

1.1

Computational Modelling of Amyloid Fibrils

Amyloid fibrils have been associated with many important pathological conditions such
as Alzheimer’s disease and type II diabetes. Amyloid fibrils also pose an important
challenge in peptide and protein drug delivery as a major degradation pathway and have
gained importance as bio-nanotubular scaffolds and triggerable drug delivery platforms 1–
6

. The rational design of drugs that inhibit fibrillation, the design of stable formulations of

peptide and protein drugs and the development of bio-nanotechnological fibril devices all
depend on understanding the structure of amyloid fibrils1. However, experimental
amyloid fibril structure determination is difficult 7. Computational method thus are
specifically useful to predict the structure of amyloid fibrils and study their dynamics and
energetics8.
There have been a few successful attempts to generate de novo computational models for
some specific amyloid fibrils 9–11, many computational studies on the mechanisms of
fibril formation8, and many methods to predict aggregation-prone regions and amyloid
forming sequences8,12–14. Nonetheless, a method for modelling any class of amyloid
fibrils starting from its sequence has been lacking until now. In this dissertation, a
computationally fast and general computational procedure, FibPredictor, is proposed to
generate structural models for any amyloid fibril, starting from its sequence.

2
1.2

Glucagon Fibrillation

Glucagon is a 29-residue peptide hormone secreted by pancreatic α-cells which plays an
important role in glucose metabolism. Currently, it is used for the emergency treatment of
hypoglycemia and as a muscle relaxant for endoscopy procedures 15. Due to poor water
solubility of this peptide in neutral pH it has to be solubilized in acidic pH. However, it is
not stable even in acidic solution and comes out of solution forming irreversible,
insoluble amyloid fibrils. Amyloid fibrils are highly stable protein constructs formed by
long β-sheets known as β-spines which interact side-by-side by entanglement of their side
chains forming a “steric zipper” 16,17.
Glucagon amyloid fibrils formation compromises the potency of drug, generates toxic
effects and increases solution viscosity which causes difficulty in delivering the
formulation using an infusion pump or injection pen 15. Because of these solubility issues,
glucagon is currently formulated as a lyophilized powder that is reconstituted just prior to
administration, and any leftover solution is discarded immediately 18. The inconvenience
and the risk of needle exposure and dosing error associated with the current formulation
has led to underutilization of glucagon despite its safety and efficacy for treatment of
insulin-induced hypoglycemia 18. Moreover, glucagon solubility issues has hindered
development of closed loop artificial pancreas device. An artificial closed loop pancreas
device can administer insulin and glucagon automatically in response to fluctuations in
blood glucose and can significantly improve quality of life for insulin dependent diabetic
patients 15. It is impractical to use the lyophilized formulation for an artificial pancreas,
which requires that an adjustable amount of glucagon solution be administered
instantaneously in response to fluctuations in blood glucose. Therefore, formulating
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glucagon as stable solution not only promotes its utilization for the current uses but also
is a major step for expanding glucagon’s therapeutic benefits. Nonetheless, in spite of
many attempts to solubilize glucagon and inhibit glucagon fibrillation such as modifying
glucagon’s chemical structure 19,20, controlling solution conditions (e.g., pH, ionic
strength) 21–24 and using stabilizing additives (e.g., cyclodextrins) 25, to date a stable
solution formulation of glucagon is not yet available in clinic.
Stable phosphorylated glucagon derivatives are introduced in this dissertation as prodrugs or active alternatives to glucagon which are soluble in neutral pH and do not show
any fibrillation for at least for one month. Penta-peptide chaperones are also tested as an
alternative method to delay glucagon fibrillation.
1.3

Outline

Chapter 2 presents penta-peptide chaperones to delay glucagon fibrillation. Although
penta-peptides delay glucagon fibrillation, their effects are limited compared to
alternative approaches, such as the one presented in chapter 5. Chapter 3 presents a
number of statistical potentials for protein structure prediction. One of these statistical
potentials is then used in the software presented in chapter 4. Chapter 4, presents a
computational method for modelling the steric zipper of amyloid fibrils. This
computational method is applied in chapter 5 to design phosphate ester derivatives of
glucagon as stable and soluble pro-drugs or active alternatives to glucagon.
I have performed the computational studies in Dr. Markus A. Lill’s lab, and the
experimental part in Dr. Elizabeth M. Topp’s lab.

4

CHAPTER 2. PENTAPEPTIDE CHAPERONES TO INHIBIT GLUCAGON
FIBRILLATION

2.1

Introduction

This chapter presents small peptide chaperones, to inhibit glucagon fibrillation. Small
peptides have previously used in other cases of problematic amyloid β-fibrils and a
number of natural and non-natural peptides have been shown to successfully inhibit
fibrillation 26–29. We go in the same direction and design small peptide chaperones to
inhibit glucagon fibrillation. Due to the particular restrictions in case of glucagon such as
high hydrophobicity and unavailability of the atomic structure for the fibril, we use a
design approach which differs from that of our predecessors. The peptides introduced in
this paper, successfully delayed glucagon fibrillation in spite of their simple structure and
small size. These peptides provide a starting point for further investigation of small
peptide chaperones for inhibiting β-fibril formation.

2.2

Materials and methods
2.2.1

Peptide design

A few natural and non-natural small peptide chaperones have shown to inhibit β-fibril
formation in Alzheimer amyloidosis. The natural peptides were designed using the
hydrophobic fragment of the target fibrillating protein as template. Proline residues were
then incorporated into the template sequence for their known β-breaker properties due to
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their special geometric and hydrogen bonding characteristics 26–28. Although this design
approach is shown to be successful in other cases, it cannot be used to design peptides to
inhibit fibrillation of our target, glucagon. Glucagon hydrophobic region is too
hydrophobic and not soluble at all. Incorporation of proline residues would only
aggravate this water insolubility resulting in insoluble peptide chaperones. The rational
structure-based design approach applied in case of previous non-natural peptides that
inhibit fibrillation is also not possible in the case of glucagon. Those non-natural peptides
were designed specifically to interact with the steric zipper region of their target fibrils
and prohibition of zipper formation inhibited fibrillation in those cases 29. This design
approach depends on availability of atomistic details of the zipper structure which is not
at hand for glucagon. Due to the challenges of β-fibril structure determination, a threedimensional atomistic structure of glucagon fibril is not yet available 7,30.
Since the template-based and structure-based design approaches were not possible in case
of glucagon, we aimed at global screening of peptides for their ability to interfere with
glucagon fibrillation. In order to limit the screening set, we focused on penta-peptides,
the shortest natural peptides with known fibrillation-inhibition properties 26. However,
even for penta-peptides, there are 205 = 3,200,000 candidates, and a comprehensive
screening was impractical. Fractional factorial design was used to design a small set of
peptides covering the whole penta-peptide space. Fractional factorial design approach has
previously used for designing small but information-rich sets of peptides 31,32 and
theoretically, a set designed in this way provides a fast and cheap way to screen the
whole peptide space for hits.
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Two numerical descriptors for amino acids (tciz1 and tciz2) introduced by Muthas et al 32
were used. The two descriptors are the first two principle components of a number of
different descriptors for amino acids. These two descriptors have been shown to capture
most of the variance in peptide sets and are calculated for many natural and unnatural
amino acids 32. There are two sets of these variables, one calculated based on only amino
acids, the other calculated based on a larger set of natural, unnatural and derivatized
amino acids 32. The latter set was used due to its larger scope and extendibility to
unnatural amino acids in later studies.
Describing each amino acid with two descriptors, each penta-peptide was described with
ten residue-position-specific variables (table 1). A 210-6 fractional factorial design table
was used (obtained from 33) (table 1). This fractional factorial design table assumes two
levels for each descriptor, and hence the values for the descriptors should be discretized
in two levels. As the current study was focused on natural peptides, the positivity or
negativity of the variable calculated based on both natural and unnatural amino acids
could not be used for discretizing the values into two levels. Therefore, the average value
of the tciz1 and tciz2 for natural amino acids was set as the zero point and all the
descriptors were transformed accordingly. The negativity and positivity of the
transformed values was the criteria to discretize the variables in two levels: positive or
negative.
Having two descriptors each with two discretized levels, amino acids were categorized
into four classes: positive-positive, negative-positive, positive-negative and negativepositive (table 2). Representative amino acids were chosen to represent each category
(table 2). T (negative-negative), F (positive-negative) and Q (negative-positive) were
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shown to be important in glucagon fibrillation in our MD simulation studies 34 and thus,
were chosen to represent their corresponding categories. H was chosen for the (positivepositive) class as it can participate in various types of interactions and its interaction
versatility may facilitate the peptide-glucagon interaction.
Substituting the representative amino acids in table 1, we obtained our set of peptides
(Table 3). From the sixteen peptides of this set, H6 and H11 were excluded due to their
very high insolubility which interferes with the experiments.

2.2.2

Sample Preparation

Glucagon at 1.6 mg/mL in 3.2 mM HCl, 0.9% NaCl (w/v) (pH 2.5) was centrifuged at
14,000 rpm for 5 min and filtered through 0.1 μm filters to eliminate any insoluble
particles. For water-soluble peptides (h1, h3, h4, h8, h9, h10, h12, h13, h14, h15 and
h16), 100 μL of the filtered glucagon sample was quickly transferred to a 96-well black
flat bottom microtiter plate in duplicate or triplicate depending on peptide availability and
incubated with 40 μL of 10 mg/ml solution of peptide in buffer and 50 μM ThT final
concentration. For peptides with less water-solubility (h2, h5, h7), 10 μL of 40 mg/ml
solution of peptide in DMSO was used. The final volume was adjusted to 200 μL using
the buffer as mentioned above. Two control triplicates of glucagon and ThT without
peptide, one without and the other with 10 μL DMSO were also prepared as standards.
Samples of peptides with ThT but without glucagon were also prepared as negative
controls as described above. Buffer was used to adjust the final volume of the control
samples to 200 μL. The plate was sealed with a clear sealing tape. Fluorescence
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measurements were carried out in a BioTek Synergy 4 Multi-Detection microplate reader
(BioTek Instruments, Winooski, VT) as described below.

2.2.3

ThT Assay

The fluorescence intensity of ThT was measured over 24 hours every 15 minutes at 23°C
with 5 s automixing before each reading with the excitation and emission wavelengths set
to 440 nm and 482 nm. Fluorescence signals exceeding 100,000 (overflow) were re-set to
100,000 for graphing purposes.

2.2.4

Intrinsic Fluorescence Assay

The excitation and emission wavelengths were set to 295 nm and 355 nm, respectively, to
look at the fluorescence of Trp25. Peptides do not have tryptophan in their sequence and
therefore do not interfere with glucagon signal. Measurement was carried out for 24 h at
23°C at 15-min intervals preceded by 5 s automixing before each reading. Very high
fluorescence signals exceeding 100,000 (overflow) were re-set to 100,000 for graphing
purposes.

2.2.5

Partial Least Square Regression

Partial least square regression (PLSR) is a common linear modelling technique for QSAR
modelling and is superior to multiple linear regression (MLR) due to its ability to build
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reliable models with numerous collinear and noisy variables. In this method, latent
independent and dependent factors are constructed aiming at maximizing correlation
between the variations of the independent and dependent ones 35.
2.2.6

MD Simulations

Initial structures of the N-terminal (residues 1–8) and C-terminal (residues 22–29)
fragments were generated from reported NMR structures of glucagon (Protein Data Bank
(PDB) ID: 1KX6)36. Three different models were selected as starting configurations for
MD simulations, and are referred to as models 1, 5, and 10 in keeping with the
numbering in the ensemble of NMR models in the original PDB file. In simulations of the
interactions of two molecules of either the 1–8 fragment or the 22–29 fragment, the
molecules were initially placed close to one another with arbitrary relative initial
orientation, maintaining at least a 4 Å distance between any two atoms in the two
fragments. Combining the conformations of the three NMR models for each fragment,
three starting configurations were generated for each of the N-terminal and C-terminal
fragment simulations. Specifically, starting configurations for both the N-terminal
fragment (1, 2, 3, 4, 5, 6, 7 and 8) and the C-terminal fragment (22, 23, 24, 25, 26, 27,
28 and 29) simulations were: model 1 with model 5, model 1 with model 10, and model 5
with model 10. All simulations were performed on capped peptides (i.e., N-terminus
acetylated and C-terminus amidated) and the side chains of His residues in the N-terminal
fragments were doubly protonated to represent the most likely state in solution at pH 2.5.
To simulate the interactions of peptide fragments, the molecules were solvated in a
preequilibrated octahedron of TIP3P water molecules, with a minimum distance of 10 Å
between the octahedron boundary and solute atoms 37. Production simulations were
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performed in an NPT ensemble using the AMBER-99SB force field with periodic
boundary conditions and an integration time step of 2 fs, applying the particle mesh
Ewald method to treat electrostatic interactions38. All bonds involving hydrogen atoms
were constrained using the SHAKE algorithm 39 and van der Waals interactions were
truncated at a distance of 10 Å. A Langevin thermostat 40 with collision frequency of 1
ps−1 was used to maintain the temperature at 298 K, and pressure was maintained at 1 atm
using isotropic position scaling with a pressure relaxation time of 2 ps. The N-terminal 1–
8 fragment simulation was neutralized by the addition of one Cl− ion per fragment. In a
simulation, the water molecules with constrained peptide(s) first were energy minimized.
The system was then gradually heated from 0 K to 298 K over a 20 ps MD simulation
period. The system was then equilibrated at constant temperature and pressure for 200 ps
and final production runs performed for 100 ns. Snapshots were saved every 0.05 ns,
resulting in 2000 snapshots for each production simulation.
A contact between residues from two molecules was identified if a distance <5 Å was
observed between any pair of atoms. Only contacts formed between two different peptide
molecules were analyzed, and not those within a single strand. All MD snapshots of the
simulations were considered for contact analysis. The frequencies of observing contacts
were first analyzed for the three separate simulations of two molecules, and then
averaged over all three simulations to obtain a single mean contact frequency. The αhelix content of each snapshot was analyzed using the DSSP software 41,42. In simulations
of two interacting peptides, snapshots were analyzed separately for each peptide. For
each amino acid, the percentage of snapshots in which it was part of an α-helix
substructure was computed for all simulations, and the mean structural content of the
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various single and two peptide molecule(s) simulations was computed. Molecules were
visualized in PyMOL 43–45 and the graphs were generated using Python and matplotlib 46.
2.3

Results

2.3.1 Glucagon interactions by MD simulation
MD simulations were performed to provide insight into structural changes and early
interactions involved in glucagon fibrillation. The α-helix content of fragment 1–8 was
negligible in simulations of either one or two molecules, the latter allowing for effects of
interaction on secondary structure (Figure 1, A and B). In contrast, the C-terminal
fragment 22–29 formed α-helices in both one- and two-molecule simulations (Figure 2, C
and D), with greater α-helix content in simulations of two molecules. To mimic the
experimental conditions, MD simulations were repeated in the presence of 0.9% NaCl for
a system containing two N-terminal fragments (model 1 with model 10) and two Cterminal fragments (model 1 with model 10). The simulations were performed for 15 ns
and compared to the first 15 ns of the salt-free simulations. Though a slight increase in
secondary structure was observed in the presence of salt, the difference in the α-helix
content was minimal (data not shown).
In light of the experimental evidence that C-terminal interactions are involved in the early
stages of fibrillation34, we aimed to identify the critical contacts for the C-C-terminal
interactions. When analyzing the contacts between amino acids, the C-terminal fragment
22–29 showed at least one contact in >94% of snapshots for all models tested. To
highlight the preferred side-chain interactions, the 10 most frequently observed contacts
averaged from three independent simulations of two molecules of the C-terminal
fragment 22–29 were identified (Figure 2). Hydrophobic interactions between amino
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acids are most frequently observed and account for eight of the 10 most frequent
interactions. In particular, Trp-25 participates in four of the 10 most frequent interactions,
i.e., with Phe-22, Val-23, Leu-26, and Met-27. Amino acids adjacent to Trp-25 also
participated in hydrophobic contacts. Phe-22, for example, is engaged in five out of the
top 10 most frequent interactions, four with hydrophobic or aromatic residues. An
aromatic T-shaped interaction between Phe-22 and Trp-25 is also among the most
frequent contacts34.

13

Figure 1 Simulations of α-helix content of glucagon-derived peptides: (A) a single
molecule of fragment 1-8, (B) two molecules of fragment 1-8, (C) a single
molecule of fragment 22-29 and (D) two molecules of fragment 22-29. The α-helix
content for each amino acid in the fragment is shown.
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Figure 2 Identification of critical contacts for the C-terminal interactions in glucagon
fibrillation under acidic conditions. The 10 most frequent contacts observed in
simulations of two molecules of glucagon fragment 22–29 are shown. Each line
represents one of the 10 interactions, which are ordered from red to blue based on
frequency. The amino acid residues are indicated by their single letter code with residue
numbers on the left.
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2.3.2

Glucagon Fibrillation

The ThT fluorescence signal increases upon interaction of ThT molecules with an
amyloid β-fibril and allows following fibrillation. Tryptophan fluorescence signal drops
as tryptophan residues get buried upon peptide aggregation and thus, provides a second
complementary method to conform ThT results 34. ThT and tryptophan intrinsic
fluorescence of glucagon were followed over 24 hours in presence and absence of each
peptide, in order to investigate the fibrillation inhibitory effects of the peptide set.
ThT fluorescence graphs (Figure 3) show that glucagon fibrillation starts with a lag time
followed by a sudden log phase and ends reaching a plateau. This is a known pattern and
is previously reported and explained by us and others 34,47. This pattern shows that once
the fibrillation passes the lag time, it fast goes to completion. Any effort to stop or reverse
the fibrillation is better to be focused on elongation of the lag time. Tryptophan
fluorescence graphs (Figure 1), although less clearly, show a general pattern similar to
ThT: a lag time and a sudden drop indicating a fast aggregation. However, the tryptophan
fluorescence patterns are less clear and definitive compared to ThT fluorescence graphs.
Nonetheless, the sudden drop in the tryptophan fluorescence, if identifiable, happens
usually close to the time that ThT fluorescence surges and verifies the lag time identified
by ThT fluorescence.
Although the lag time-log phase-plateau pattern is generally preserved across DMSOand water-soluble peptides, the shape of the graphs are slightly different between these
two groups. The difference is most salient in the standard glucagon samples with no
peptide, where the DMSO containing standard show a less definitive plateau compared to
the other standard not containing DMSO. Also the lag time for the glucagon standard is
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shorter in presence of DMSO compared to the no DMSO standard sample. This indicates
that DMSO interferes with the fibrillation process and make it slightly faster. None of the
peptides show fibrillation of their own (graphs not shown) and the glucagon containing
samples were the only ones which showed fibrillation.
Although the general patterns of ThT and tryptophan fluorescence graphs were preserved
in presence or absence of peptides, the lag time varied significantly in presence of
peptides as discussed in detail in the next section.
2.3.3 Fibrillation lag time extension
Figure 4 shows the lag time difference between the standard glucagon without any
peptide and glucagon in presence of each of the peptides. All of the peptides studied
affected the fibrillation lag time and except H7, all of them elongated the lag time. The
most effective peptide H8 (QFFTQ) elongated the fibrillation lag time for more than 700
minutes resulting in a total lag time of nearly 1000 minutes. H8 is water soluble and its
solubility in addition to its effectiveness make it a promising hit for glucagon fibrillation
inhibition.
There is considerable variation between the effects of different peptides on the fibrillation
lag time. This variation shows the lag time elongations are not due to general presence of
any peptide, but are in fact the sequence-specific. Note that the sequence of these
peptides are composed of only four different residues and the variation between the
sequences is very limited. Nonetheless, even this limited sequence variety results in
considerable divergence in fibrillation inhibitory effects. Variation in inhibitory effects of
the DMSO-soluble peptides shows the effect is not reducible to simple physical
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properties such as hydrophobicity and supports sequence-specificity of the inhibitory
effects.
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Figure 3 ThT and Tryptophan fluorescence over time. The dotted y=4000 line indicates
the cutoff for end-of-lag-time identification.
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Figure 3 continued
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Figure 3 continued
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Figure 4 The glucagon fibrillation lag time difference between the samples containing
various peptides and the standard no-peptide samples. Bars related to water soluble and
DMSO soluble peptides are colored in grey and white respectively. Water soluble and
DMSO soluble peptides were compared with their corresponding standard samples.
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Figure 5 Root mean squared error of the predicted lag time differences with experimental
values vs number of factors in the PLS model
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Figure 6 Measured lag time difference vs predicted lag time difference
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Figure 7 Distribution of calculated lag time differences with standard for all possible
penta-peptides
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2.3.4

PLS model

Figure 5 shows the root mean squared error between the predicted lag time differences
with standard and the experimental measurement (rmsep) vs the number of latent
independent factors included in the PLS model. The figure shows improvement in rmsep
up to three factors. Figure 6 shows the predicted lag time difference with standard vs the
measured values for the PLS model with three latent factors. Based on these results the
PLS model with three latent factors was used to predict the lag time difference with
standard for all possible penta-peptides. The results are shows in Figure 7. According to
these predictions, there are many candidate penta-peptides that can delay fibrillation, and
the study suggests hit penta-peptides, such as QFFTQ. However, the maximum delay will
be limited to around two thousand minutes (≈33 hours) which is not enough for practical
uses of glucagon.
2.4

Conclusions

Protein aggregation poses an important challenge for therapeutic formulation of proteins
48

. Glucagon fibrillation is an example where the therapeutic benefits of a peptide drug is

significantly limited by low stability of its formulation. Many attempts to stabilize
glucagon have not yet resulted in its soluble formulation in clinic. This studies the
potential of small peptide chaperones, more specifically penta-peptides, to inhibit
glucagon fibrillation. We also suggested a hit penta-peptide sequence: QFFTQ. The
fibrillation inhibitory effects of these peptides is sequence-specific. This opens a path
towards developing more effective and more potent glucagon fibrillation peptide
inhibitors. However, the limited delay predicated for these penta-peptides is not enough
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to solve glucagon formulation problem. Other paths (such as the chemical modification
of glucagon presented in the next chapters) should be pursued.
The methods and the results presented in this paper have implications even beyond
glucagon fibrillation. Amyloid β-fibrils are involved in many serious pathological
conditions and are important drug targets 49. The present work and its predecessors show
that small peptide chaperones have the potential to successfully inhibit amyloid βfibrillation and underscore the importance of small peptide chaperones for drug
development. However, peptide drug design is challenging due to the combinatorially
large number of candidate sequences. The peptide design approach used in this study can
provide a general guideline for the initial steps of designing small peptide libraries.
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Table 1 210-6 fractional factorial design table; each row corresponds to one peptide
Amino acid 1

Amino acid 2 Amino acid 3 Amino acid 4 Amino acid 5

tciz1

tciz2

tciz1

tciz2

tciz1

tciz2

tciz1

tciz2

tciz1

tciz2

-1
+1

-1
-1

-1
-1

-1
-1

-1
+1

-1
-1

-1
+1

-1
+1

+1
-1

+1
-1

-1
+1
-1

+1
+1
-1

-1
-1
+1

-1
-1
-1

+1
-1
+1

+1
+1
+1

-1
+1
+1

+1
-1
-1

-1
+1
-1

-1
+1
+1

+1

-1

+1

-1

-1

+1

-1

+1

+1

-1

-1

+1

+1

-1

-1

-1

+1

+1

+1

-1

+1

+1

+1

-1

+1

-1

-1

-1

-1

+1

-1

-1

-1

+1

-1

+1

+1

+1

-1

+1

+1
-1
+1

-1
+1
+1

-1
-1
-1

+1
+1
+1

+1
+1
-1

+1
-1
-1

-1
+1
-1

-1
-1
+1

+1
+1
-1

-1
-1
+1

-1
+1

-1
-1

+1
+1

+1
+1

+1
-1

-1
-1

-1
+1

+1
-1

+1
-1

+1
-1

-1

+1

+1

+1

-1

+1

-1

-1

-1

-1

+1

+1

+1

+1

+1

+1

+1

+1

+1

+1
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Table 2 Four classes of amino acids based on the two-level discretization of tciz1 and
tciz2 variables.
tciz1
-1
+1

tciz2
-1
-1

-1
+1

+1
+1

Amino acids
A, T, S, C
V, L, I, M, F,
W
N, D, Q, E
K, H, R, T
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Table 3 training set; each row corresponds to one peptide
Peptide code aa 1 aa2 aa3 aa4 aa5
H1
T
T
T
T
H
H2
F
T
F
H
T
H3
Q
T
H
Q
T
H4
H
T
Q
F
H
H5
T
F
H
F
Q
H6
F
F
Q
Q
F
H7
Q
F
T
H
F
H8
H
F
F
T
Q
H9
T
Q
Q
H
Q
H10
F
Q
H
T
F
H11
Q
Q
F
F
F
H12
H
Q
T
Q
Q
H13
T
H
F
Q
H
H14
F
H
T
F
T
H15
Q
H
Q
T
T
H16
H
H
H
H
H
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CHAPTER 3. ARE DISTANCE-DEPENDENT STATISTICAL POTENTIALS
CONSIDERING THREE INTERACTING BODIES SUPERIOR TO TWO-BODY
STATISTICAL POTENTIALS FOR PROTEIN STRUCTURE PREDICTION?

3.1

Introduction

Protein structure prediction still represents a significant challenge to computational
biophysics. Recently developed statistical scoring functions have proven to be a valuable
tool for identification of the native structure among a typically large set of candidate
structures 50,51. These potentials are typically based on the assumption that the total free
energy of a protein structure can be computed by the sum of all pairwise free energies
(∆𝐺(𝑟𝑖𝑗 ))

∆𝐺𝑡𝑜𝑡 = ∑ ∆𝐺(𝑟𝑖𝑗 )

Eq. 1

𝑖<𝑗

where i and j are either interacting bodies e.g. individual atoms of the protein or
representative points for each amino acid, e.g. the Cα atom etc. The pairwise free
energies are often calculated based on the pairwise distribution function (P(rij)) between a
specific pair of atom types or amino acids, i and j
𝑃(𝑟𝑖𝑗 ) =

−∆𝐺(𝑟𝑖𝑗 )
1
exp(
)
𝑍
𝑅𝑇

Eq. 2

31
where Z is the partition function, R is the gas constant and T is the temperature.
Therefore, the inverse Boltzmann equation used to calculate ∆𝐺(𝑟𝑖𝑗 ) would be:

∆𝐺(𝑟𝑖𝑗 ) = −𝑅𝑇 𝑙𝑛 𝑃(𝑟𝑖𝑗 ) − 𝑅𝑇 𝑙𝑛 𝑍

Eq. 3

Typically ∆𝐺(rij ) (the potential of mean force (PMF)) is computed with respect to a
reference state R representing a hypothetical system with uniform and unbiased
interactions between the different atom types or amino acids. The relative free energy
between a pair of atoms or residues i and j with respect to this reference state is then
computed by
∆𝐺(𝑟𝑖𝑗 ) = −𝑅𝑇 ln

𝑃(𝑟𝑖𝑗 )
𝑃𝑅 (𝑟𝑖𝑗 )

− 𝑅𝑇 ln

𝑍
𝑍𝑅

Eq. 4

The pairwise distribution function can be computed by measuring the frequency of pairs
of atom types at a given distance using databases of experimentally solved protein
structures 52. An early example of such potential functions is developed by Samudrala
and Moult. Their function models potentials of atomistic interactions based on the
pairwise distance between two interacting bodies 51.
The underlying assumption of Eq. 1, that the total free energy of a protein structure can
be computed by the sum of all pairwise free energies, however, is not physically justified.
More precisely, the exact free energy of a system is determined by the statistical
mechanical relationship between the N-body distribution function and the free energy51.
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∆G(r1 , … , rN ) = −k B T ln P(r1 , … , rN ) − k B T ln Z

Eq. 5

Thus Eq. 1 neglects correlation effects between multiple atoms or amino acids in a
protein. In order to model these higher order interactions a number of multi-body contact
based statistical potentials have been developed. Most of these statistical potentials are
based on Delauney tessellation - a geometric technique to identify the neighboring bodies
53–57

, although some other geometric approaches have also been investigated
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. To the

best of our knowledge none of these multi-body potentials look into the details of
distance between interacting residues. Also they usually use very coarse-grained
representations of interactions e.g. interaction between residues and do not model
interactions between various atom types. Based on this discussion, we asked the question
if we can model details of three-body interactions using distance dependencies between
pairs of pairwise interactions between atomistic interacting bodies. More precisely we
hypothesized that considering the presence of a third body adds valuable information to
statistical potentials based on interaction pairs. This additional information of multi-body
interactions may improve the scoring process and consequently the identification of
native protein structures.
The importance of three-body terms in determining the stability of globular forms of
polymers has been established long ago, and by analogy their inclusion in statistical
potentials for protein native structure detection has been conjectured 59. The importance
of multi-body interactions in protein folding has been shown independently using other
computational methods 57,60, which makes the idea of building a multi-body distancebased statistical potential for protein structure determination seem even more promising.
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In this study, we generated a distance-based quasi-three-body statistical potential for
atom-based interacting bodies and analyzed if we can identify dependence between
multiple pair-wise interactions. We investigated the effect of the distance from a third
body on the pairwise distance of two interacting partners.
We developed statistical potentials describing the simultaneous interaction of three
bodies that represent important physical elements of the protein and used it to
differentiate native protein structures from decoys. Those elements characterize either
physicochemical properties of the protein, which we call the physicochemical elements
throughout the paper (hydrogen-bond acceptors and donors, negatively and positively
charged, hydrophobic, and aromatic groups), Amber atom types, or amino acid Cα atoms.
We assumed that the presence of the third interacting element affects the pairwise
distribution function of the other two interacting elements by altering the energetically
optimal distance between the two interacting bodies. We also used three simple counting
scoring functions (counting hydrophobic centers or Cα's within a certain distance from
each other and counting the number of hydrogen bonds) in order to investigate if using
more sophisticated and computationally costly methods perform better compared to very
simplistic approaches.
In order to assess the performance of different scoring functions, we tested the functions’
ability to separate decoys from native protein structures. Three different decoy sets were
utilized to evaluate the performance of the scoring functions for protein structure
prediction 61. The performances of our quasi-three-body scoring functions were compared
to existing method including FoldX, DFIRE2, dDFIRE, GOAP, Rosetta, and simple
counting methods.

34
3.2
3.2.1

Materials and Methods

Assigning the properties to proteins

Statistical potentials were derived between different elements characterizing the
physicochemical and structural properties of a protein structure. Physicochemical
properties of a protein were defined as hydrophobic (H), hydrogen-bond donor (D),
acceptor (A), and aromatic (R) properties and formally charged functional groups (P for
positively charged, N for negatively charged,). For a given protein, the physicochemical
elements were assigned as follows: Hydrophobic elements were assigned to carbon and
sulfur atoms that are not bonded to an oxygen or nitrogen atom. For assigning hydrogen
bond donors and acceptors, hydrogen atoms were added to the protein structure using
Open Babel 2.3.1. Hydrogen bond acceptor and donor physicochemical elements were
included in the generation of statistical potentials only if they form intra-protein hydrogen
bonds, discarding unpaired hydrogen bonds. The following criteria were used to define
hydrogen bonds: The distance between a donor group and the acceptor atom must be
closer than 4.6 Å, the angle between donor heavy atom, donor hydrogen and the acceptor
heavy atom needs to be in the range 120-180°, and the angle between acceptor lone-pair,
acceptor heavy atom and the donor hydrogen must be smaller than 45°. Acceptor and
donor elements were then assigned to the acceptor and donor heavy atoms. It should be
noted that although only acceptor or donor groups that are engaged in hydrogen bonds are
considered in the analysis, triplets can freely contain one partner independent of the other
as well as both partners. An aromatic physicochemical element was assigned to the
center of each aromatic ring, i.e. to the side chains of Phe, Tyr, His and Trp. Negatively
and positively charged physicochemical elements were assigned to Glu, Asp, Arg and
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Lys specific side chain atoms. Scoring functions constructed from physicochemical
elements are denoted by “Phys_” in their names. We also generated statistical scoring
functions based on analyzing quasi-three-body and two-body interactions using all heavy
atoms classified by Amber99 atom types. These scoring functions are denoted by
“Amb_”. Two additional scoring functions are based on quasi-three-body and two-body
interactions among the Cα atoms of all residues; no classification with respect to amino
acid attributes was used. These scoring functions are denoted by “Ca_”. Throughout this
paper we call the scoring functions resulting from the quasi-three-body approach as
quasi-three-body scoring functions (denoted by the suffix “_3b_score”) to differentiate
them from the two-body scoring functions (denoted by suffix “_2b_score”) resulting from
pair-wise distance distributions. Physicochemical elements, Amber atom types and amino
acid Cα atoms were assigned using in-house software.
3.2.2

Protein database for generation of statistical potential

To generate the statistical potentials, 1000 non-redundant protein structures were chosen
from the PDB databank by clustering proteins into groups based on their pairwise
sequence similarity and picking a representative from each group using the online tool
VAST.
3.2.3

Interacting Pairs and Triplets

For each set of properties (physicochemical elements, Amber atom types and Cα atoms)
pair-wise and quasi-three-body statistical potentials were derived for all possible
combinations of properties. For pair-wise potentials the frequency of each pair of
properties A and B as a function of distance is stored in histograms (𝐹𝑖𝐴𝐵 ) where i
represents one of 32 distance bins with a bin width of 0.25 Å. Distances between 2 to 10
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Å are considered in our analysis. Throughout the paper, parentheses around vectors and
matrices like those around (𝐹𝑖𝐴𝐵 ) refers to the vector or matrix as a whole, and lack of
these parentheses denotes an element in that vector or matrix
For quasi-three-body interactions, we extend pair-wise statistical potentials to triplets of
interacting properties using a novel geometric approach. The three distances AB, AC, and
BC unambiguously describe the relationship of the triplet of interacting elements A, B,
and C (Fig. 8-B). The corresponding histogram would require for each triplet of
properties data sampling for 323=32,768 bins (32 bins per distance). Obtaining sufficient
experimental data for such a large number of bins is impractical. To address this
sampling problem, we reduced the dimensionality of the triplet by reducing the
description of triplet interactions to two distances spawning from a center point (Fig. 1A). As a consequence, three different pairs of distances (Fig.8-A) with different center
element can be formed which constitute different statistical potentials, i.e. (AB, BC) with
center B, (BA, AC) with center A, (AC, CB) with center C. Therefore each triplet is
defined by its center and the two other elements (Fig. 8-A). Consequently, the full threebody statistical potential is reduced to two pairs of conditional pair-wise interactions,
which we named quasi-three-body potentials throughout this study.
Each of the properties is used as the center of the triplet, and all of the combinations of
other properties that form triplets with this center are computed. For example, for six
different physicochemical elements 126 triplets were formed. A two-dimensional
distance matrix (𝐹𝑖𝑗𝐴𝐵𝐶 ) for each triplet ABC (center: B) is computed with a distance
range from 2.0 to 10 Å, and a bin size of 0.25 Å. The bin number for distance AB and BC
𝐴𝐵𝐶
are i and j. (𝐹𝑅,𝑖𝑗
) is the same matrix populated based on the reference state described
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below. A vector (𝐹𝑖𝐴𝐵 ) is used to store distance data in a similar way for two-body
𝐴𝐵
interactions. (𝐹𝑅,𝑖
) stores the distance data for pair-wise interactions in the reference
𝐴𝐵𝐶
𝐴𝐵
state. (𝐹𝑖𝑗𝐴𝐵𝐶 ) , (𝐹𝑅,𝑖𝑗
) , (𝐹𝑖𝐴𝐵 ) , (𝐹𝑅,𝑖
) vectors and matrices of each triplet or pair are
𝐴𝐵𝐶
𝐴𝐵
normalized to one to give the probabilities (𝑃𝑖𝑗𝐴𝐵𝐶 ) , (𝑃𝑅,𝑖𝑗
), (𝑃𝑖𝐴𝐵 ) , (𝑃𝑅,𝑖
).

3.2.4

Statistical potential and definition of reference state

The quasi-three-body and two-body statistical potentials are derived from the elements of
the distance matrix 𝑃𝑖𝑗𝐴𝐵𝐶 and vector 𝑃𝑖𝐴𝐵 using Boltzmann inversion:
𝐵𝑖𝑗𝐴𝐵𝐶

= −𝑅𝑇 ln

𝑃𝑖𝑗𝐴𝐵𝐶
𝐴𝐵𝐶
𝑃𝑅,𝑖𝑗

Eq. 6

and
𝐵𝑖𝐴𝐵

𝑃𝑖𝐴𝐵
= −𝑅𝑇 ln 𝐴𝐵
𝑃𝑅,𝑖

Eq. 7

for interacting triplets and interacting pairs respectively. R is the gas constant, T is the
temperature, and (𝐵𝑖𝑗𝐴𝐵𝐶 ) and (𝐵𝑖𝐴𝐵 ) are matrices of the individual quasi-three- and two𝐴𝐵𝐶
body interaction terms of a statistical potential. If 𝑃𝑅,𝑖𝑗
is equal to or less than 410-6 or if
𝐴𝐵
𝑃𝑅,𝑖
is equal to or less than 210-4, 𝐵𝑖𝑗𝐴𝐵𝐶 or 𝐵𝑖𝐴𝐵 are set to zero respectively in order to

avoid artificially high values due to division by a value close to zero.
A randomized state with no specific interactions between the protein-describing elements
is generated to serve as reference state. In generating the random state we adopted a
𝐴′𝐵′𝐶′

shuffling approach 62: randomized state matrices (𝑃𝑅,𝑖𝑗 ) are generated by assigning
each triplet ABC from a protein structure with given distance bins i and j to the same
distance bins but randomized properties A’, B’, and C’. For example, a donor-acceptor-
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aromatic triplet with distance bins i=6, j=15 will be assigned to the same distance bins
𝐴′𝐵′𝐶′

i=6, j=15 in the random 𝑃𝑅,𝑖𝑗

matrix where A’B’C’ might be any random triplet of

properties such as acceptor, positively charged, hydrophobic, etc.. In this way, the
random state matrices for different triplets preserve the shape and associated interaction
distances of the proteins used in the analysis. As the reference state has a protein-like
shape, the resulting scoring function will not be biased towards decoys solely by having a
protein-like shape. Using an ideal gas to generate the random matrix would not remove
the inherent shape and density dependency of the statistical potential from the protein
shape. In other words, the ideal gas reference state produces a random spherical
distribution of properties, and all protein structures, native and decoy, would already vary
significantly from this reference state due to having a protein-like shape.
For the Ca_score scoring function, there is only one type of triplet or doublet which
makes the use of the randomization method described above infeasible. In this scoring
measure, for each protein, a 1 Å grid is overlaid onto the protein structure. The protein’s
shape is reproduced by those grid points whose x, y and z coordinates of a grid point fall
between the x, y and z coordinates of any two Cα's of the protein respectively. Then the
same number of Cα atoms of a protein are randomly distributed onto those grid points
that cover the shape of the protein with a minimum distance of 1.5 Å between any two
Cα atoms. This distribution generates a pseudo protein corresponding to each protein
structure and is used as the reference state for that protein.
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3.2.5

Smoothed Potential

smthd_Phys_2b and _3b potentials were generated by smoothing Phys_2b and _3b using
a cubic spline. Every other bin was been used as a knot and the fitted cubic spline was
then used to calculate the values for the other bins.
3.2.6

Scoring

The total scores result from the summation of sub-scores corresponding to all individual
pairs or triplets in a protein: Matrices (𝐶𝑖𝑗𝐴𝐵𝐶 ) or vectors (𝐶𝑖𝐴𝐵 ) are constructed for each
protein by counting the number of observations for each triplet ABC or pair AB in the
distance interval corresponding to bin ij or bin i, respectively. The sub-score for each
triplet ABC (SABC) or pair (SAB) is then calculated using the following formula:
𝑆𝐴𝐵𝐶 = ∑(
𝑖,𝑗

𝐶𝑖𝑗𝐴𝐵𝐶 . 𝐵𝑖𝑗𝐴𝐵𝐶
𝑑𝑖2 . 𝑑𝑗2

)

Eq. 8

and
𝑆𝐴𝐵

𝐶𝑖𝐴𝐵 . 𝐵𝑖𝐴𝐵
= ∑(
)
𝑑𝑖2

Eq. 9

𝑖

𝑑𝑖 is the AB distance and 𝑑𝑗 is the BC distance in angstroms. Division by 𝑑𝑖2 ∙ 𝑑𝑗2 and 𝑑𝑖2
normalizes the frequency of observing interacting bodies with respect to their distance
from the central body of the triplet. The total quasi-three-body and two-body scores are
then calculated by summing over all quasi-three-body or two-body sub-scores.
3.2.7

Other scoring functions used for comparison

To evaluate the performance of our statistical scoring functions for identifying the native
protein structure, the following existing scoring functions and some simplistic counting
methods were used for comparison:

40
3.2.7.1 Simple Counting Methods
Two dominant interaction types are often considered to be main forces for the stability of
proteins: the hydrophobic effect and hydrogen bonding
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. For comparison with our

statistical scoring function, these two underlying forces are represented in two very
simplistic counting methods to differentiate native structures from decoys. The number of
hydrophobic atoms within 5 Ȧ distance of each other (count_Phob_score), and the
number of hydrogen bonds formed (count_H_score), were considered. The final simple
counting scoring function measures the compactness of the protein by counting the
number of Cα’s within 5 Ȧ distance of each other Cα atom (count_Ca_score).
3.2.7.2 Conventional Scoring Functions
Four widely used scoring functions, DFIRE2, dDFIRE, GOAP, FoldX and Rosetta
(called conventional scoring functions in this paper) are tested for comparison. Details of
these scoring functions is as follows and more can be found in the cited references:
FoldX: FoldX uses an empirical scoring function that calculates the free energy by linear
combination of several empirical terms describing various energetic contributions to the
stability of protein structures (e.g. van der Waals energy, hydrogen bond energy etc.):
∆G = a.∆Gvdw + b.∆GsolvH + c.∆GsolvP + d.∆Gwb + e.∆GHbond
Eq. 10
+ f.∆Gel + g.∆Gkon + h.T∆Smc + k.T∆Ssc + l.∆Gclash
in which a, b,…,l are relative weights of different energies and T is temperature. ∆Gvdw
represents van der Waals interactions and is calculated based on experimental data of
vaporizing amino acids from water. ∆GsolvH and ∆GsolvP represent desolvation energies of
hydrophobic and polar groups respectively and are calculated based on experimental data
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on transferring amino acids from aqueous to organic solvents. ∆Gwb represents the energy
of water molecules forming more than two hydrogen bonds with the protein. ∆GHbond
represents hydrogen bonding energies and is computed based on data resulted from
engineered double mutant cycles. ∆Gel is the electrostatic interaction energy and is
computed using Coulomb’s law. ∆Gkon is an additional electrostatic component between
atoms of different polypeptide chains. ∆Smc and ∆Ssc are entropic penalties for restraining
the backbone and side chains in a certain conformation and is calculated based on results
of statistical analyses on protein structures. ∆Gclash is a measure of the energy penalty
associated with steric clashes between different atoms.
FoldX can be used to investigate the destabilizing/stabilizing effects of point mutations
on protein structure. The executable of FoldX (version 6.0) was downloaded from
foldx.crg.es.
Rosetta: Rosetta scoring function includes a combination of statistical and physical
scoring terms. The terms of the scoring function include residue solvation, residue pair
interactions, strand-pairing, arrangement of strands into sheets, helix packing, radius of
gyration, Cβ density which is related to solvation, steric repulsion, preferred torsions in
the Ramachandran map, Lennard-Jones interactions, hydrogen-bonding, solvation,
electrostatic and disulfide interactions of various residues, energies of different rotamer
states, and unfolded state reference energy. Details on these terms in Rosetta can be
found in the cited references. We used Mini-Rosetta 3.3 downloaded from
rosettacommons.org
DFIRE and dDFIRE: DFIRE potential stands for Distance-scaled Finite-Ideal gas
Reference potential and is a statistical energy function based on distances observed
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between pairs of atom types in known protein structures. The atom types are residue
specific which resulted in a total of 167 atom types. The pair energy is calculated using
the following equation:
𝑢̅𝐷𝐹𝐼𝑅𝐸 (𝑟𝑖𝑗)
𝑁𝑜𝑏𝑠 (𝑖, 𝑗, 𝑟)
−𝑅𝑇 ln
,
𝑟 𝛼 ∆𝑟
= {
(𝑟 ) (∆𝑟 )𝑁𝑜𝑏𝑠 (𝑖, 𝑗, 𝑟𝑐𝑢𝑡 )
𝑐𝑢𝑡
𝑐𝑢𝑡
0,

𝑟 < 𝑟𝑐𝑢𝑡

Eq. 11

𝑟 ≥ 𝑟𝑐𝑢𝑡

in which R is the gas constant, T is temperature (300 K), α equals 1.61, Nobs(i,j,r) is the
number of (i,j) pairs within the sphere with radius r observed in the structure database, rcut
is 14.5 Ȧ, and ∆r (∆rcut) is the bin width at r (rcut).
dDFIRE potential stands for dipolar DFIRE. The difference between DFIRE and dDFIRE
is that the latter takes the angles between interacting dipoles into consideration thus
accounting for dipole-dipole interactions.
The executables were downloaded from
sparks.informatics.iupui.edu/yueyang/download/index.php?Download=dDFIRE1.1bin.tbz and
sparks.informatics.iupui.edu/yueyang/download/index.php?Download=DFIRE2.1bin.tbz.
GOAP: A plane is associated with each heavy atom defined by the heavy atom and its
two neighbor bonded heavy atom. A local coordinate system (𝜗𝑥 , 𝜗𝑦 , 𝜗𝑧 ) is defined based
on this plane. Two polar angles ψ and θ and a torsional angle χ are defined based on this
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coordinate system (for details look at the cited reference).The GOAP potential, then, is
defined as follows:

𝐸(𝑟𝑎𝑏 , 𝜃𝑎 , 𝜓𝑎 , 𝜃𝑏 , 𝜓𝑏 , 𝜒) = −𝑅𝑇

𝑃𝑜𝑏𝑠 (𝑟𝑎𝑏 , 𝜃𝑎 , 𝜓𝑎 , 𝜃𝑏 , 𝜓𝑏 , 𝜒)
𝑃𝑒𝑥𝑝 (𝑟𝑎𝑏 , 𝜃𝑎 , 𝜓𝑎 , 𝜃𝑏 , 𝜓𝑏 , 𝜒)

Eq. 12

where a and b represent atom types of the two interacting partners, rab is the distance,
𝑃𝑒𝑥𝑝 (𝑟𝑎𝑏 , 𝜃𝑎 , 𝜓𝑎 , 𝜃𝑏 , 𝜓𝑏 , 𝜒) is the probability observed in the reference state and
𝑃𝑜𝑏𝑠 (𝑟𝑎𝑏 , 𝜃𝑎 , 𝜓𝑎 , 𝜃𝑏 , 𝜓𝑏 , 𝜒) is the probability observed in known protein structures. It
should be noted that GOAP benefits from the DFIRE reference state and uses different
equations for indifferent cut-offs. For details please refer to the cited reference.
3.2.8

Decoy Sets

Three different decoy sets from Decoys ‘R’ Us version 1.3 (dd.compbio.washington.edu)
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were used to test the performance of the various scoring functions for differentiating

native protein structures from decoys. These decoy sets differ by the type of proteins and
the method employed to generate the decoys. The details of these decoy sets are as
follows.
hg_structural: This set contains decoys for 29 globin proteins. For each protein,
comparative modeling with all other globins in the set was performed to generate decoys
for each of the proteins; hence each globin set contains 28 decoy structures in addition to
the native structure. All structures were energy minimized using ENCAD 22.
vhp_mcmd: This set focuses on the thermostable domain of villin (1vii). 6255 structures
were selected from snapshots of five 100 ns MD simulations, four of them producing

44
decoy sets and one of them which is based on the X-ray structure generating native-like
structures. The decoy trajectories were generated starting from conformations obtained
from a coarse-grained MC simulation. All the structures were energy minimized with
MM/GBSA using CHARMM. The set contains 1251 native and 5004 decoy structures.
fisa: This set is generated from four small alpha-helical proteins (1fc2, 1hdd-C, 2cro, and
4icb). The main chains for the decoys were modeled by fragment-insertion simulated
annealing and Bayesian scoring functions based on fragments from proteins with similar
local sequences. Then the SCWRL software package was used to model the side
chains. All the structures were energy minimized using CHARMM22b. 500 decoys for
each of these four proteins were generated (a single file ackcalb11-min.pdb related to
4icb was missing so one of the sets has 499 decoys).
Considering the differences between these decoy sets, different strategies were used to
calculate the area under the curve (AUC) in their corresponding scoring experiments (see
section 3.2). Unlike vhp_mcmd which has only one sub-set (1vii), hg_structural and fisa
have 29 and 4 sub-sets respectively with only one native structure in each sub-set. Hence,
while the number of native structures found was used for calculating the AUC for
vhp_mcmd, we used the number of sub-sets with identified native structure to calculate
the AUCs for fisa and hg_structural. For hg_structural, identification of a structure with
RMSD less than 2 Å with the native structure was considered equivalent to identification
of the native structure.
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Figure 8 A) ABC triplet (AB,BC) with center B (yellow) and BAC triplet (BA, AC)
with center A(red). Each triplet is defined with a center and two other points, hence it
comprises two distances. Changing the point considered as the center will lead to a a
different triplet as the new triplet would have one common and one different distance
compared to the previous triplet. B): Three distances observed in a triplet: AB (green),
BC (yellow), and AC (red). By choosing a center, there will be only two distances in
each triplet (Fig.1-A).
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3.3

Results and Discussions

Scoring functions are named based on prefixes and suffixes introduced in the Materials
and Methods section. For a brief description of the scoring functions please refer to Table
4.
3.3.1

Quasi-three-body pseudo-potentials

We first wanted to investigate if the presence of a third interaction site or body C does
have any effects on the pairwise interaction of two other bodies A and B. If such an
influence is not present, then ABi (AB pair having distance corresponding to bin i) and
BCj (BC pair having distance corresponding to bin j) would be independent variables for
all bins i, j. In such a case a cut of (𝑃𝑖𝑗𝐴𝐵𝐶 ) along a specific j, would generate a contour
that reproduces the pattern of probability density (𝑃𝑖𝐴𝐵 ) multiplied (or scaled) by the
value of 𝑃𝑗𝐵𝐶 for that specific bin j, i.e. 𝑃𝑖𝑗𝐴𝐵𝐶 = 𝑃𝑗𝐵𝐶 ∙ 𝑃𝑖𝐴𝐵 . If C has no influence on the
interaction profile of AB, this similarity in contour should be observed for any i, j.
Therefore multiple contours of (𝑃𝑖𝑗𝐴𝐵𝐶 ) for different j should have the same pattern with
different scaling factors. This pattern should also match that of the corresponding
pairwise interactions. However, observing different patterns in the contour maps and
those also which differ from the corresponding pairwise pattern, would mean that the
(𝑃𝑖𝐴𝐵 ) distribution is influenced by j (BC distance) which implies a statistical dependency
of ABi and BCj. Dependency between ABi and BCj means that there is higher order
information in (𝑃𝑖𝑗𝐴𝐵𝐶 ) not implied in either (𝑃𝑖𝐴𝐵 ) or (𝑃𝑗𝐵𝐶 ) which could be used in
differentiating native from decoy structures.
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Using the abovementioned strategy, we can visualize the existence of any dependency
between ABi and BCj in (𝐵𝑖𝑗𝐴𝐵𝐶 ). (𝐵𝑖𝑗𝐴𝐵𝐶 ) and (𝐵𝑖𝐴𝐵 ) are calculated based on (𝑃𝑖𝑗𝐴𝐵𝐶 ) and
(𝑃𝑖𝐴𝐵 ) using Eq. 6 and 7 respectively as described in detail in Materials and Methods and
are the statistical potentials used in our scoring functions (see Eq. 8 and 9). Figures 9 and
10 are graphs of (𝐵𝑖𝑗𝐴𝐵𝐶 ) and (𝐵𝑖𝐴𝐵 ) for a number of representative triplets ((𝐵𝑖𝑗𝐴𝐵𝐶 )
graphs for all of the triplets can be found in figure 12). The examples of (𝐵𝑖𝑗𝐴𝐵𝐶 ) shown in
figure 9 represent the effects of the presence of a third body on the potential of interaction
between hydrogen-bond donors (D) and acceptors (A) and the (𝐵𝑖𝑗𝐴𝐵𝐶 ) shown in figure 10
represent such effects on interactions between two hydrophobic (H) elements. The
contours of each three-dimensional plot are also shown on each side of the graph. The
(𝐵𝑖𝐴𝐵 ) corresponding to pairwise interactions is shown with the red line overlaid on the
contours on each side of the graph. For HHX potentials (X referring to the third
physicochemical elements) we see very high positive peaks at distances less than 3.5 Å
(see figure 12) which can be attributed to van der Waals clashes. These peaks overwhelm
the scaling of the rest of the graph which makes observation of discernible patterns
difficult. In order to examine the pattern of contours in HHX potentials, the first 8 bins
were ignored. The trimmed potentials were then re-plotted (figure 10). It is noteworthy
that the potential from the beginning bins (~2.5-3.5 Å) dominates the whole potential for
nearly all of the triplets.
Despite small fluctuations the (𝐵𝑖𝑗𝐴𝐵𝐶 ) graphs in figures 9 and 10 have contours that
generally follow the same pattern. Also the pattern of contours is the same as the pairwise
interaction potentials. This demonstrates lack or weakness of higher order information in
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(𝐵𝑖𝑗𝐴𝐵𝐶 ) and shows the potentials have not been highly influenced by introducing the third
interacting body. Lack of higher order information observed in the ADX triplets could be
related to the fact that the AD interactions are dominated by backbone-backbone
interactions leading to the formation of secondary structure elements of the protein, thus
they are less susceptible to the presence of a third interacting body.
In addition to visual comparison of patterns in the quasi-three body and two-body
distance-dependent statistical potentials, we aimed to quantify the lack of difference
between those patterns. Using the underlying quasi-three body and two-body probability
distribution functions, we performed Kolmogorov-Smirnov tests (K-S tests). K-S test
compares a test sample with a reference sample and identifies if they originate from the
same probability distribution. In our study, the null hypothesis to be tested states that the
two samples, i.e. the pair-wise distribution functions and the corresponding slices of the
quasi-three body function, originate from the same probability distribution. The null
hypothesis is tested against a certain significance level where a typical value of 0.05 is
used in this study 64,65
In detail, all two-body contours (𝑃̂𝑖𝐴𝐵 ) and (𝑃̂𝑗𝐴𝐵 ) were obtained from bins 4 to 32 for
each three-body probability distribution 𝑃𝑖𝑗𝐴𝐵𝐶 . Each of the contours was normalized. The
contours were tested against their corresponding two-body distributions (𝑃𝑖𝐴𝐵 ) and (𝑃𝑗𝐵𝐶 )
obtained from an analysis of the same protein database. The first three bins were
excluded from the analysis since they cover distances between 2.0 and 2.75 Ȧ for which
typically only few if any observations were made in the database. For each triplet, there
are a total of 58 pattern comparisons, 29 for each of the two pairwise interactions
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embedded within a triplet. Out of 126 triplets, only 9 triplets violate the null hypothesis in
more than 10% of the comparisons and only two triplets in more than 20% of the
comparisons (Table 5). 77 triplets do not violate the null hypothesis at all, i.e. the
probability distributions of quasi-three body interactions are identical to the
corresponding pair-wise interactions for all slices with a significance level of 0.05. The
results show that higher order information is not established for almost 93% of all
triplets. All of the triplets that violate the null hypothesis in more than 10% of all
comparisons (Table 5) contain positive-negative (PN) or negative-only interactions
(NNN). Whereas these results may be interpreted as engagement of charged atoms in
higher order interactions, it should be noted that interaction triplets containing two
charged atoms are relatively rare compared to all other triplets studied, and that the small
sample size of those triplets might at least contribute to the relatively frequent violation
of the null hypothesis.
Figure 11 shows the statistical potential for triplet APN that displays the most significant
higher order interactions based on the KS-test. The shallow maximum in the region
AP=3.0-5.0 and PN=5.0-8.0 might represent an instance of higher order interactions in
this potential map.
3.3.2 Quasi-three-body scoring functions
KS-test analysis demonstrated that there are only a few three-body potentials with
significant higher order interactions. Consequently, a significant improvement in scoring
performance is not expected between quasi- three-body distance-dependent potentials and
their two body counterparts. The following study was designed to support this argument
in a practical application setting. We constructed statistical potentials to test whether or
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not the influence of a third body on the interaction profile between two particles would
improve the performance of the potential in its ability to discriminate native-like
structures from decoy structures. The graphs resulted from using various scoring
functions tested for vhp_mcmd, hg_structural and fisa decoy sets can be found in
Supplementary Material (figures 13, 14 and 15). The area under the curve (AUC)
(ranging 0 to 1) of these graphs are plotted in figure 16 and can be used for comparison
between different scoring functions.
In general the scoring functions developed in this study are very successful in identifying
native structures from decoys. Our scoring functions perform perfectly on the fisa decoy
set displaying highest AUC (equal to the ideal scoring function). Also these scoring
functions have very good performances which are comparable to or better than the
conventional scoring functions for vhp_mcmd and hg_structural decoys sets. This
observation is important as it supports our idea of using protein structure prediction as a
practical test case for comparing quasi-three body and pairwise atomistic statistical
potentials. Although Ca_2b_score and Ca_3b_scores are not as successful as the rest of
our pairwise and three body scoring function for two of the decoy sets, it is hard to
identify one representation of the interacting bodies which always leads to superior
performance. Also there is not a significant difference between scoring performance of
smthd_Phys_score and Phys_score and they almost overlap. Simple counting methods
have good performances in fisa and show better or comparable results compared to
conventional scoring functions.
The general linear correlation in figure 16-A implies similar scoring performances of
three-body and pairwise functions. In fact except one case (Ca_3b_score for fisa), we do
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not observe a significant improvement or deterioration in scoring performance by
switching between pairwise and three-body functions.
Examples of approximate time needed for calculations of two main steps for pairwise and
quasi-three body scores are shown in table 6. The first step is populating (𝐶𝑖𝑗𝐴𝐵𝐶 ) or
(𝐶𝑖𝑗𝐴𝐵 ) and normalizing them with distance squared (d2). The second step is multiplication
of distance-normalized (𝐶𝑖𝑗𝐴𝐵𝐶 ) by (𝐵𝑖𝑗𝐴𝐵𝐶 ) to calculate 𝑆𝐴𝐵𝐶 and 𝑆𝐴𝐵 (equations 8 and 9).
Although pairwise scoring takes less time, quasi-three-body scoring is still extremely
fast. For instance, the total time needed for qusi-three-body scoring of the largest protein
tested (153 amino acids) is less than 4 sec.
3.3.3

Correlations between different scoring functions

In order to investigate potential correlations between the various scoring functions tested
in this study, we calculated the Pearson correlation coefficient between scores obtained
from the various scoring functions for each subset in all decoy sets. Specifically, a high
correlation between two-body and quasi-three-body scores can be additional evidence for
the lack of higher order information in quasi-three-body potentials. Figure 17 graphically
shows correlations for selected subsets of various decoy sets. The correlation heat maps
for all subsets of all decoy sets can be found in the Supplementary Material (Figure 18).
Figure 17 shows correlation between the scoring functions for the vhp_mcmd decoy set
(represented by 1vii). In general, all of the corresponding two-body and quasi-three-body
scoring functions show very high correlations (> 0.8) with each other. Excluding the
Ca_3b_score and Ca_2b_score scoring functions, the remainder of the two-body and
quasi-three-body statistical scoring functions and the four studied conventional scores
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(dDFIRE, DFIRE2, GOAP, Rosetta, FoldX) are highly correlated (>0.7 with DFIRE2,
dDFIRE, FoldX, and >0.6 with Rosetta, GOAP). Correlation coefficients between
various scoring functions for the hg_structural decoy set (as represented by 2pgh-A
subset in figure 17) follow the same general pattern as the vhp_mcmd. We again see
high correlations (>0.8) between two-body and quasi-three-body scores in this decoy set.
There is much less correlation among the physicochemical element-based statistical
scoring functions, dDFIRE, DFIRE2, GOAP, FoldX and Rosetta for the fisa decoy set.
Similar to vhp_mcmd and hg_structural decoy sets scores based on Cα's are weakly
correlated with our other scores (figure 17) although they are highly correlated with each
other (>0.7). The high correlation (>0.6) between two-body and quasi-three-body scores
is repeated in this decoy set.
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Figure 9 Graphs of (𝐵𝑖𝑗𝐴𝐵𝐶 ) (quasi-three-body statistical potential for interacting triplet ABC
with distance bins i and j) of a number of representative triplets (indicated by the three letter
code on top of each graph). Only interactions with pairwise distances between 2 to 10 Å are
considered. The contours of each plot (darker colors for bins with larger distances) are shown
on each side of the graph. The corresponding (𝐵𝑖𝐴𝐵 ) (two-body pseudo-statistical potential for
interacting pair AB with distance bins i) is shown by a red line overlaid onto the contours.
These quasi-three-body pseudo-potentials show the effects of the presence of a third body on
the potential of interaction between hydrogen bond donor (D) and acceptor (A) elements
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Figure 10 Graphs of (𝐵𝑖𝑗𝐴𝐵𝐶 ) (quasi-three-body statistical potential for interacting triplet
ABC with distance bins i and j) of a number of representative triplets (indicated by the
three letter code on top of each graph). Only interactions with pairwise distances between
2 to 10 Å are considered. The contours of each plot (darker colors for bins with larger
distances) are shown on each side of the graph. The corresponding (𝐵𝑖𝐴𝐵 ) (two-body
pseudo-statistical potential for interacting pair AB with distance bins i) is shown by a red
line overlaid onto the contours. These quasi-three-body pseudo-potentials show the effects
of the presence of a third body on the potential of interaction between two hydrophobic
(H) elements.
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Figure 11 Graph of (𝐵𝑖𝑗𝐴𝑃𝑁 ) (quasi-three-body statistical potential for interacting triplet
APN with distance bins i and j). Only interactions with pairwise distances between 2 to
10 Å are considered. The contours of the plot (darker colors for bins with larger
distances) are shown on each side of the graph. The corresponding (𝐵𝑖𝐴𝑃 ) and (𝐵𝑖𝑃𝑁 )
(two-body pseudo-statistical potential for interacting pair AP and PN respectively with
distance bins i) is shown by a red line overlaid onto the contours. APN shows the most
significant higher order interactions compared to pairwise interactions.
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Figure 12 Graphs of (𝐵𝑖𝑗𝐴𝐵𝐶 ) of a number of representative triplets (indicated by the three
letter code on top of each graph). Only interactions with pairwise distances between 2 to
10 A are considered. The contours of each plot (darker colors for bins with larger
distances) are shown on each side of the graph. The corresponding (𝐵𝑖𝐴𝐵 ) (two-body
pseudo-statistical potential for interacting pair AB with distance bins i) is shown by red
line overlaid onto the contours.
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Figure 12 continued
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Figure 13 Number of sub-sets in vhp_mcmd decoy set that their native structure is ranked
among various top percentages of structures, by A) dDFIRE, DFIRE2, FoldX, Rosetta,
B) two-body and quasi-three-body scoring functions, and C) by simple counting methods
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Figure 14 Number of native structures in hg_structural decoy set ranked among various
top percentages of structures, by A) dDFIRE, DFIRE2, FoldX, Rosetta, B) two-body and
quasi-three-body scoring functions, and C) simple counting methods.
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Figure 15 Number of sub-sets in fisa decoy set that their native structure is ranked in
among various top percentages of structures, by A) dDFIRE, DFIRE2, FoldX, Rosetta,
B) two-body and quasi-three-body scoring functions, and C) simple counting methods.
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Figure 16 A) AUCs resulted from quasi-three-body scores vs AUCs of their two-body
scores in different decoy sets tested. Comparison of pairwise to quasi-three body scoring
functions shows little differences in structure-prediction quality. B) AUCs resulted from
conventional scoring functions and simple counting methods. Result for vhp_mcmd, fisa,
and hg_structural are represented by ,  and .

Figure 17 Pearson correlation coefficient among
various scoring functions in 2cro from fisa,
2pgh-A from hg_structural and 1vii representing
vhp_mcmd.
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Figure 18 : Pearson correlation coefficient among 1- Phys_2b_score 2- Phys_3b_score
3- Amb_2b_score 4- Amb_3b_score 5- CALPHA_2b_score 6- CALPHA_3b_score 7FoldX 8- Rosetta 9- dDFIRE 10- DFIRE2. The title of each graph shows ‘decoy set :
subset of the decoy set’
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Figure 18 continued
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3.4

Conclusion

Calculating the free energy of a protein system using statistical potential derived from
pair-distribution functions is not physically justified. Theoretically, for using statistical
potentials to compute the total free energy of a protein system, the energies should be
expressed in terms of multi-body interaction terms. Various multi-body potentials have
been developed based on this theoretical argument. Higher order information and better
scoring performances are reported for those multi-body potentials57,66–68. To the best of
our knowledge, however, all of those multi-body potentials are based on a coarse-grained
representation of interacting bodies and are contact-based. In this study, we asked the
question if higher order information is also important for distance-dependent statistical
potentials that are based on an atomistic representation of the interacting bodies.
Our results indicate that the multi-body interaction energies are dominated by pairwise
interactions, with small contributions from higher order interactions, resulting in the lack
of significant difference between pairwise and quasi-three-body potentials. In contrast to
our initial hypothesis, we have seen in the majority of cases a lack of distance
dependency between two pairs of interacting bodies constituting quasi-three-body
statistical potentials. Higher order interactions can only be established in few triplets
modeling interactions between charged atoms. In other words, besides charge
interactions, considering the effect of the distance of a third interacting body on the pair
distribution function of two other interacting bodies utilizing the methods we presented in
this study adds negligible additional information to the statistical potential. Considering
scarcity of charged bodies in protein structures compared to other types of interacting
bodies, similar performance of two-body and quasi-three-body scores is not surprising.
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This similar performance can be attributed to the lack or weakness of such higher order
information in quasi-three-body potentials. We see a very high correlation between
corresponding quasi-three-body and two-body scores which is in line with similarities in
the patterns of contour maps observed in quasi-three-body and two-body potentials.
The scoring functions developed in this study show higher or comparable performances
with the four conventional scoring functions tested. We also obtain good results for many
systems from simple counting scoring functions designed to model hydrophobic or
hydrogen bond interactions. High performance of these simple counting approaches can
be attributed to the decoy sets not being sufficiently challenging. Also it can imply that
hydrogen bonding and hydrophobic effect can adequately be used to differentiate native
structures from decoys in many protein systems. It is not surprising considering the
importance of these interactions in the protein folding process69.
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Table 4 Brief description of the scoring functions generated throughout the study.
Score Title

Description

count_Ca_score
count_Phob_score
count_H_score
Phys_2b_score
Phys_3b_score
smthd_Phys_2b_score
smthd_Phys_3b_score
Amb_2b_score
Amb_3b_score
Ca_2b_score
Ca_3b_score

Number of Cα’s within 5 Ȧ distance of each other
Number of hydrophobic atoms within 5 Ȧ distance of each other
Number of hydrogen bonds formed
Two-body score based on physicochemical elements
Quasi-three-body score based on physicochemical elements
Phys_2b smoothed by a cubic spline
Phys_3b smoothed by a cubic spline
Two-body score based on AMBER atom types
Quasi-three-body score based on AMBER atom types
Two-body score based on Cα atoms
Quasi-three-body score based on Cα atoms
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Table 5 Triplets with more than 10% violations of null hypothesis in KS-test: Normalized
contours of quasi-three-body joint probability distributions are compared with the
corresponding two-body probability distribution using KS-test. Out of 126 triplets, nine
triplets violate null hypothesis that distributions are the same for more than 10% of all
distance slices.
Triplet
APN
DPN
HPN
PPN
RPN
NNN
RPN
NPN
HNP

Number of violations of null hypothesis with significance
level of 0.05
43
12
11
7
7
6
6
6
6
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Table 6 Examples of time needed for calculations of main steps of quasi-three-body and
pairwise scoring (precision of 1 msec)

protein

decoy set

NATIVE_13
2
2cro
1emy

vhp_mcmd
fisa
hg_structura
l

#amino
acids

36

Populating
(𝑪𝑨𝑩𝑪
𝒊𝒋 )
and
normalizin
g with d2
0.124

65
153

0.399
2.916

Populating
(𝑪𝑨𝑩
𝒊𝒋 ) and
normalizin
g with d2

Calculatin
g 𝑺𝑨𝑩𝑪

Calculating
𝑺𝑨𝑩

0.002

0.001

0

0.005
0.033

0.001
0.001

0
0
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CHAPTER 4. FIBPREDICTOR: A COMPUTATIONAL METHOD FOR RAPID
PREDICTION OF AMYLOID -FIBRIL STRUCTURES

4.1

Introduction

In this chapter, a computationally fast and general computational procedure, FibPredictor,
is proposed to generate structural models for any amyloid fibril, starting from its
sequence. Despite the efficiency of the algorithm, the generated models are accurate in
generating experimental structures among the top-5 ranked models, for providing a
description of the structural landscape available to an amyloid fibril forming sequence
and can be used as initial structures for more sophisticated computational studies.
FibPredictor is available at http://nanohub.org/resources/fibpredictor.
The following two-step procedure of Fibpredictor was developed to generate amyloid
fibril structures: For a given protein sequence, an ensemble of candidate amyloid fibril
structures is generated comprehensively representing the amyloid fibril conformational
space accessible to that specific sequence. This ensemble contains representative
structures from all eight classes of amyloid fibrils. These eight classes are described in
table 7 and figure 19. Further details can be sought at the cited references 16,30. Using a
scoring function developed for protein-structure prediction, the most energetically
favorable candidate structures are then identified comprising the suggested computational
models of amyloid fibrils.
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None of the individual steps of this computational procedure includes time consuming
and computationally expensive methods, such as molecular dynamics simulations, so the
procedure is computationally efficient and easy to implement. Validity of the approach is
demonstrated by reproducing the experimentally determined structures of six amyloid
fibrils.
4.2

Materials and Methods

4.2.1 Input for Fibpredictor
The minimum necessary input for the program Fibpredictor are the sequences of all
strands within each of the interacting β-spines. β-spines are β-sheets which interact with
each other side-by-side to form the full amyloid fibril. The sequences of each individual
strand within each β-spine can be identical or different, covering various cases of amyloid
fibrillation. The number of β-strands and their length should be the same for both βspines.
4.2.2

Generating the structural ensemble

Figure 20 summarizes the procedure for generating the structural ensemble of amyloid
fibrils. First, coordinates of the backbone atoms (Cα, C, O and N) are generated for one
of the β-spines as a regular β-sheet. These strands should have the same number of
residues. Two separate sets of coordinates are generated, one as a parallel and the other as
an anti-parallel β-sheet. For each set of coordinates, the normal vector of the approximate
sheet formed by all Cα’s is determined. This normal vector is calculated by averaging
over normal vectors of all planes formed by any three Cα’s. This vector is then tilted and
elongated randomly within a user-defined range of values for tilt angles and elongation
length. This process defines a translation vector, which will be used to place the
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backbone of the second β-spine. The ranges for tilt angles and elongation lengths in the
current study were set to 45 degrees and 3.5 - 14 Å, respectively, but can be adjusted by
the user to the target amyloid fibril specifications. Note that in order to adjust these
specifications, no knowledge about the details of the structure of the target amyloid fibril
is necessary. Instead, the length of the side chains in their fully extended conformations
can be used to set the maximum distance between the sheets. The length of the fully
retracted conformations of the side chains, on the other hand, can be used to set the
minimum distance between the sheets. Initial hypotheses on the probable types of
interactions between certain amino acids on the first and the second sheet can be used to
limit the range of the tilting angles.
Multiple translation vectors are randomly generated to create structural options for the
second β-spine relative to the first β-spine. It is necessary to sample relative positions for
the two β-spines which can lead to proper entanglement of the side-chains, creating a
strongly interacting steric zipper. Fifty translation vectors were used for this study. For
each of these translation vectors, the backbone atom coordinates of the first β-spine are
copied along the translation vector to generate the backbone coordinates of the second βspine. In addition to simple copying of the coordinates, rotation operations are performed
on the second -spine to generate other members of the eight potential classes of amyloid
fibrils. Rotation around the z-axis generates similar or different directionalities of the spine (classes two, three, six and eight) and rotation around the x-axis generates face-toface or face-to-back steric zippers (classes one, three, five and eight). In summary, the
different copies of the second -spine are generated by simple copying or by additional xrotation, z-rotation or zx-rotations. These rotations result in four different amyloid fibril
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classes for each of the initial parallel and anti-parallel backbone coordinates comprising
all eight classes of amyloid fibrils. Table 7 shows the initial β-sheet conformations and
rotations used to generate each of the eight classes.
Each of these initial backbone structures is then passed to the side-chain prediction
program SCRWRL4 which adds all sidechains to the backbone using a rotamer library
aiming to minimize the SCWRL4 scoring function 70.
4.2.3 Scoring the ensemble structures
We tested three different scoring functions to identify the most energetically favorable
candidate structures in the ensemble: GOAP, Amb_3b, and the SCWRL4 internal scoring
function. The SCWRL4 internal scoring function is used by SCWRL4 to predict the
energetically lowest side chain orientations 70. SCRWL4 uses a rotamer library and
calculates the self-free energy and the pair-wise free energy of the different rotamers
using a scoring function including terms describing intra- and intermolecular interactions
such as hydrogen bonding and van der Waals interactions. For more details the reader is
referred to 70.
GOAP71, is a statistical scoring function widely used in homology modelling, especially
as part of the homology-modelling software MODELLER72. GOAP defines a plane with
each heavy atom and two other neighboring bonded heavy atom and associates a local
coordinate system (𝜗𝑥 , 𝜗𝑦 , 𝜗𝑧 ) with this plane. Two polar angles ψ and θ and a torsional
angle χ are then defined using this coordinate system. The GOAP potential, then, is
calculated as shown in Eq. 12.
Amb_3b is a statistical scoring function developed in our lab, which has shown better
performance than a number of conventional scoring functions including Rosetta and
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FoldX in differentiating native from decoy protein structures in three different protein
structure ensembles 73. Interacting partners are represented as AMBER atom types. The
total energy of the protein structure is then determined using a pre-calculated quasi-three
body statistical potential as shown below:
𝐴𝑚𝑏_3𝑏 = ∑

𝐴𝐵𝐶

∑(

𝐶𝑖𝑗𝐴𝐵𝐶 . 𝐵𝑖𝑗𝐴𝐵𝐶

𝑖,𝑗

𝑑𝑖2 . 𝑑𝑗2

)

Eq. 13

Where A, B and C represent interacting partners, ABC refers to any possible quasi-three
body interaction, i and j refer to the discretized distance between the first and second, and
second and third interacting partners, di and dj represent the interaction distances in
angstroms, 𝐶𝑖𝑗𝐴𝐵𝐶 is the frequency of each triplet ABC in the distance interval
corresponding to i and j and 𝐵𝑖𝑗𝐴𝐵𝐶 is the pre-calculated quasi-three body potential for
ABC interaction in distance i and j.
4.2.4 FibPredictor usage and GUI
A graphical user interface (GUI) was developed for FibPredictor (Figure 21) allowing the
user to specify the options of the software and export the results. For complete details on
usage the reader is referred to user’s manual available on
https://nanohub.org/resources/fibpredictor/supportingdocs. The most important options
are described in more detail in the following.
4.2.4.1 Sequences of the first and the second sheets:
FibPredictor models amyloid fibrils as two β-sheets parallel or antiparallel to each other.
Each β-sheet consists of two or more β-strands. The user can enter the sequences of the
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strands of the first (top box) and the second (bottom box) β-sheet in one-letter amino-acid
code.
4.2.4.2 Sense of the β-sheets:
Amyloid fibrils can be formed by parallel or anti parallel β-sheets. FibPredictor can
generate both types of backbone structure for amyloid fibrils, but the user can limit the
modelling to only one types if experimental data on the sense of the target amyloid fibril
does exist.
4.2.4.3 Scoring function:
Either the Amb_3b or GOAP scoring function, or both, can be chosen for ranking the
ensemble of generated amyloid fibril models. The SCWRL4 internal scoring function is
always used internally in FibPredictor as part of the side-chain optimization using
SCWRL. Amb_3b is computationally more efficient than GOAP and can be used for
initial modeling studies. A consensus scoring scheme using all of the three available
scoring functions may allow for the most robust ranking of the structure models.
4.2.4.4 Rotations:
Rotations of one β-sheet with respect to the other are used to generate the various classes
of amyloid fibrils. All types of rotations should be chosen unless experimental data allow
some amyloid classes to be eliminated.
4.2.4.5 Number of randomly generated models (Rand. models):
This variable specifies the number of translation vectors generated to place the second
sheet relative to the first sheet, randomly somewhere in the chopped cone (Figure 20).
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With increasing number of random vectors, the chance of obtaining good models
increases at the cost of reduced computational efficiency.
4.2.4.6 Top models:
This variable determines the number of top-ranked structures provided as output to the
user, based on the selected scoring function. This output allows the user to perform a
more focused analysis of the predicted amyloid fibril models.
4.2.4.7 Minimum distance between the sheets:
This variable specifies the minimum distance between the sheets and should provide
enough space between the sheets to accommodate side chains in the steric zipper
conformation in a fully entangled conformation (Figure 20 and Figure 22-A).
4.2.4.8 Distance variation between the sheets:
This variable specifies the variation between minimum and maximum distance of the two
sheets when generating the amyloid fibril structure models. The distance separation for
each model will be a random number within this range (Figure 20 and Figure 22-A).
4.2.4.9 Angle variation between the sheets:
This parameter specifies the maximum horizontal translation of the second sheet with
respect to the first sheet for investigating different entanglements of sidechains between
the sheets (Figure 20 and Figure 22-B).
4.2.5

Validation

In order to demonstrate the ability of Fibpredictor to correctly model amyloid β-fibrils,
we aimed to reproduce the experimentally determined structure of six β-fibrils. The
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corresponding PDB-IDs of the six structures are 3OVL (class1)74, 3HYD (class 1),
2ONV (class 4), 3OW9 (5), 2OMQ (class 7) and 2ONA (class 8) 16. Despite the
increasing number of amyloid fibril structures deposited in the protein data bank, only a
small fraction are suitable for validating our structure prediction method because many of
the deposited structure lack either the β-sheet or the steric zipper portion of amyloid
fibrils.
Using an in-house program based on BioPython, all computational models generated for
each of these six systems were superimposed on their corresponding reference PDB
structure and their root mean square deviation (RMSD) from the experimental structure
was calculated for all heavy atoms.
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Figure 19 Eight classes of amyloid fibrils. Molecular models do not represent any natural
fibril and are only presented to highlight the different classes. For more details refer to
Table 1 and reference 16.
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Figure 20 Procedure for generating computational candidate models for
amyloid structures (example PDB ID: 2ONA). Multiple translation vectors are
generated randomly and for each candidate structure four separate structures
are generated using rotation operations.
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Figure 21 Fibpredictor GUI
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Figure 22 Minimum distance, distance variation (A) and angle variation (B) parameters
in FibPredictor. The green schematic represent the initial β-sheet. The blue schematics
represent the copied β-sheets.

105
4.3

Results and discussion

Figure 23 shows the modelled structures with the lowest RMSD, superimposed on their
reference PDB X-ray crystal structures. For all of the six amyloid fibril test systems,
FibPredictor generates structures with an RMSD less than 2.5 Å from the reference PDB
structure. This demonstrates the feasibility of the computational sampling procedure to
generate ensembles which contain fibril structures very close to the experimentally
observed structure.
In order to investigate the accuracy of the three tested scoring functions for identifying
the native fibril structures in the generated ensembles, an enrichment analysis was
performed. For each protein system, the ensemble structures belonging to the class of the
amyloid reference structure were ranked according to the three different scoring
functions. The percentage of near-experimental structures (RMSD <3 Å) identified as a
function of scoring rank of all predicted structures was plotted in the enrichment graphs
shown in Figure 24; the underlying scatter plots are shown in Figure 25. The performance
of an ideal scoring function and that generated by a random ranking of the structures are
also shown for comparison. We observe that the results of the scoring functions usually
are significantly better than random selection and sometimes even approach the ideal
enrichment. This means that the scoring functions are generally successful in identifying
the correct fibril structures. Overall, GOAP is the most successful scoring function in
four of the test systems and Amb_3b is the best scoring function for the other two fibril
systems. Within the correct class of amyloid fibril, the first native-like model is identified
among the top 5 ranked structures with both GOAP (3OVL, 3HYD, 2ONV, 3OW9,
2OMQ) and Amb_3b (2ONA, 3HYD, 2ONV, 3OW9, 2OMQ). For the remaining tested
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amyloid fibrils, the first native-like model appears among the top 10 structures for both
GOAP and Amb_3b.
Although the scoring functions were successful in enriching native-like structures among
the top-ranked structures within one class, they failed to differentiate between classes.
Figure 26, for example, displays GOAP scores as a function of RMSD for the 2OMQ
system. The graphs of the other scores and amyloid fibril systems follow the same
general pattern (Figure 25). Although there are small differences between various classes,
there are always predicted structures with favorable scores which belong to classes other
than that of the reference structure and thus have high RMSD. This, however, does not
necessarily mean that the scoring functions failed in identifying favorable structures, as
structural polymorphism is widely observed in amyloid fibrils 75–77. Hence, it is likely
that the structure represented by the reference PDB is only one of several amyloid fibril
structures energetically accessible to the peptide sequence. Structures with favorable
scores but high RMSD may represent other polymorphs of the β-fibril as they display
steric zipper interactions of potentially similar strength as the crystallized form of the
fibril.
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Figure 23 Predicted structure (carbon atoms in white) with the lowest RMSD value
superimposed to their experimental reference PDB structure (orange) for the six fibril
structures investigated in this study.
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Figure 24 Enrichment plots for the four amyloid classes using three different scoring
functions, showing the percentage of identified near-experimental fibril structures as a
function of ranked ensemble structures. The reference PBD ID, its amyloid class, sense of
the initial sheet (parallel (par) or anti-parallel (antipar)) and applied rotation operations
(none, z, x or zx) are included in the title of each graph.
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Figure 25 Various scores vs. RMSD for all of the six amyloid systems tested. The
triangle shows the score of the reference PDB structure.
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Figure 25 continued
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Figure 25 continued
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Figure 25 continued

113

Figure 25 continued
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Figure 25 continued
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Figure 25 continued
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Figure 25 continued
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Figure 25 continued
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Figure 25 continued
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Figure 25 continued
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Figure 25 continued
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Figure 26 GOAP score vs. RMSD for 2OMQ fibril. The triangle displays the score of the
reference PDB structure.
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4.4

Conclusions

In this paper, we have reported a general, computationally efficient method for structure
prediction of amyloid fibrils. We have demonstrated that native-like amyloid fibril
structures can be generated based on the sequence alone. Currently, due to the lack of
knowledge about potential structural polymorphism of amyloid fibrils, it is unclear
whether the method identifies the most energetically favorable class of amyloid fibril for
a peptide sequence, or whether equally favorable amyloid fibril structures for the same
sequence exist. Thus, FibPredictor results should be combined with experimental data to
determine the sense of the amyloid β-spine 78, to reduce the analysis to a small subset of
fibril classes. In such cases, FibPredictor demonstrated the ability to identify the correct
amyloid fibril structures among the top-ranked conformations.
The structures generated by our program can also be useful in interpreting experimental
data, e.g., by fitting them to SAXS spectra or for interpreting residue interactions
observed by NMR. Fibpredictor results can also be combined with more sophisticated but
computationally demanding simulation methods to further refine the initial predicted
structures, identify potentially important interactions in amyloid fibrils, study mechanical
properties of amyloid fibrils79,80 and quantify the free energies of amyloid fibril stability.
Finally, analysis of ensembles of energetically favorable structures generated by
FibPredictor can be used to identify important interactions in the steric zipper.
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Table 7 Eight classes of amyloid β-fibrils 16 and the rotation operations used by
FibPredictor to generate each amyloid class. Figure 19 presents visualization of the
different fibril classes.
Class

Sense of β- Directions of Steric Zipper
the two βSheet
sheets

Rotation
operation

1

Parallel

Up-up

Face-to-face

X

2

Parallel

Up-up

Face-to-back

Z

3

Parallel

Up-down

Face-to-face

ZX

4

Parallel

Up-down

Face-to-back

No rotation

5

Anti-Parallel

Up = down

Face-to-face

X

6

Anti-Parallel

Up = down

Face-to-back

Z

7

Anti-Parallel

Up-up

Face = back

No rotation

8

Anti-Parallel

Up-down

Face = back

ZX
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CHAPTER 5. PHOSPHATE ESTER DERIVATIVES OF GLUCAGON

5.1

Introduction

In this chapter stable phosphorylated glucagon derivatives are introduced as glucagon
pro-drugs which are soluble in neutral pH. Phosphate groups which can be removed upon
administration by serum phosphatases have been successfully used in past to enhance
small molecule and peptidomimetic drug solubility and delivery 4–6,81,82. Also,
phosphorylation has been shown to be able to affect fibril formation of small peptides
5,6,83–88

. Based on the idea of phosphate derivate prodrugs and phosphate-mediated

fibrillation modulation, we designed stable and soluble phospho-glucagon prodrugs. This
design was based on a rigorous computational analysis which suggested that
phosphorylation at certain rationally-picked residues can effectively prevent fibrillation.
The enhanced solubility and chemical and physical stability of these prodrugs are shown
by various methods. Also results show the phosphate group can be removed
enzymatically in phosphatase enzyme concentrations close to serum conditions, resulting
in free native glucagon.
5.2
5.2.1

Materials and Methods

Phosphorylation Sites and Possible Phospho-glucagon Prodrugs

There are 10 readily phosporhylatable sites on glucagon (i.e., His1, Ser2, Thr5, Thr7,
Ser8, Tyr10, Ser11, Tyr13, Ser16, Thr29), which means there are hypothetically 10
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singly phosphorylated, 45 doubly phosphorylated and 120 triply phosphorylated possible
glucagon prodrugs carrying between one and three phosphate groups, a total of 175
distinct molecules. Allowing for up to ten sites of phosphorylation, the number of
distinct phospho-glucagon derivatives increases to 1023. This study is focused on
phospho-glucagon derivatives containing only one phosphate group, since these are the
simplest to produce and serve to demonstrate the approach.
5.2.2

Computational Modelling of Glucagon Fibrils

Crystal structures of a glucagon fibril have not been resolved yet. Therefore,
computational modeling was used to rationally identify strategies for inhibiting glucagon
fibrillation. Small angle X-ray scattering (SAXS) 30 and Fourier transform infrared
(FTIR) spectroscopy data of glucagon fibril structures21 were used to limit the possible
geometries for glucagon fibrils. FTIR data21 shows that the glucagon fibril is formed by
antiparallel β-sheets. SAXS data shows that the glucagon fibril has a diameter of 45 Å,
which is half of the length of a fully extended glucagon. This suggests that glucagon folds
onto itself and is not fully extended in its fibril form. Combining the SAXS data with
FTIR, only two different fibril classes remain possible for glucagon. Each of these classes
can form steric zipper by entanglements of side chains on two sides of the β-sheet which
results in four formations in total (Figure 28).
Due to impreciseness inherent to the SAXS data, however, it is not clear how many of the
amino acids engage in forming the steric zipper, how many form the loop and how many
terminal residues are free and unstructured. With a loop length ranging from 3 to 17
amino acids and allowing zero, one or two free terminal amino acids yields 64 possible
fibril formations (Figure 29). Moreover, each of these fibril formations can fold in two
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different directions (Figure 28) doubling the number of possible formations. FibPredictor,
a program developed in the investigators’ lab for computational modelling of steric
zipper regions of amyloid fibrils89, was then used to generate 100 candidate structures for
each of 128 formations, amounting to 12,800 structural models covering a comprehensive
set of hypothetically possible structures for the geometries compatible with the SAX and
FTIR data. Fibpredictor models the steric zipper by first placing the backbone atoms of
the two sheets within a user defined minimum and maximum distance (and a certain
range of tilting angles). Then the side chains are optimized for each relative position of
the two sheets using SCWRL4 70 and the energy of the final structure model is calculated.
Fibpredictor has two options for scoring, GOAP71 and Amb_3b73. For this study, we used
the GOAP score to identify energetically favorable models.
From the 128,000 steric zipper models, the top 500 most energetically favorable were
investigated by an in-house program for the most frequent inter-residue contacts. To
overcome the preference for larger models, the energy was normalized by the number of
residues. A pair of residues with any two heavy atom closer than 5 Å to each other were
considered as a contact.
5.2.3

MD Simulations

The model of glucagon steric zipper generated by FibPredictor with the lowest average
energy per residue among all models (NOP) (Figure 29A) and three phosphorylated
analogues (Figure 29B) were simulated to investigate the effect of phosphorylation on the
stability of the steric zipper. The phosphorylated analogues represented the
phosphorylated steric zipper in three different protonation states: doubly protonated
(SEN)90, singly protonated (S1P) and not protonated phosphate group (SEP)91. NOP,
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SEN and S1P were simulated in pH 2.5, and SEP was simulated in pH 7.4 to reproduce
different experimental conditions of fluorescence studies described below. The proteins
were solvated in a pre-equilibrated octahedron of TIP3P water molecules with a
minimum distance of 20 Å between the box boundary and any solute atom37. Simulations
were performed using the AMBER constant pH force field 92.
The shake algorithm was used to constrain hydrogen containing bonds 39. The
simulations were performed in an NPT ensemble. The temperature was maintained at 298
K with a Langevin thermostat40 with collision frequency of 1 ps-1. Isotropic position
scaling with pressure relaxation time of 2 ps was used to maintain pressure at 1 atm. The
electrostatic interactions in periodic boundary conditions were treated using the particle
mesh Ewald method 38. The cut-off for van der Waals interactions was set to 10 Å. The
integration time step was 2 fs.
The water molecules and peptide were energy minimized first with and then without
restraints. The system was then heated from 0 K to 298 K gradually over a 20 ps. The
system was then equilibrated in an NPT ensemble for 100 ps. The main production MD
runs were performed for 60 ns. 1200 snapshots were saved for each production
simulation. Contacts were defined as two residues on the two sides of the steric zipper
with closest distance to each other. The terminal amino acids were excluded from this
study due to their flexibility. Initial contacts were defined as contacts that were identified
in the initial equilibrated structure. Contacts were defined between two closest amino
acids on the two sides of the steric zipper. The contacts were tracked over the full
simulation length using an in-house python code.

128
5.2.4

Peptides and their solubility

Research grade human glucagon was purchased from ProSpec (East Brunswick,
NJ). Phosphorylated-glucagon derivatives were purchased from GenScript (Piscataway,
NJ). Solubility of glucagon derivatives were reported by GenScript.
5.2.5

Stability study (24 h)

Glucagon, phospho-Ser2-, phospho-Thr5- and phospho-Ser8-glucagon were prepared at
1.6 mg/mL in 3.2 mM HCl, 0.9% NaCl (w/v) (pH 2.5) and phospho-Thr5-glucagon and
phospho-Ser8-glucagon were prepared at 1.6 mg/ml in 1X phosphate buffer saline (PBS),
pH 7.4. Samples were centrifuged at 14,000 rpm for 5 min and filtered through 0.1 μm
filters to remove any insoluble material. 100 μL of the filtered samples were quickly
transferred to a 96-well black flat bottom microtiter plate in triplicate and incubated with
50 μM ThT final concentration. The final volume was adjusted to 200 μL using the
corresponding buffer as mentioned above. The plate was sealed with a crystal clear
sealing tape. Fluorescence measurements were carried out in a BioTek Synergy 4 MultiDetection microplate reader as described below.
5.2.6

Initial stability study (31 days)

Phospho-Thr5- and phospho-Ser8-glucagon were prepared at 1 mg/mL in 50 mM sodium
phosphate, pH 7.4. Samples were centrifuged at 14,000 rpm for 5 min and filtered
through 0.1 μm filters to remove any insoluble material. 100 μL of the filtered samples
were quickly transferred to a 96-well black flat bottom microtiter plate in triplicate and
incubated with 50 μM ThT final concentration. The final volume was adjusted to 200 μL
using 50 mM sodium phosphate, pH 7.4. For monitoring fibrillation under different
temperature conditions, all the samples were prepared in three separate plates. The plates
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were sealed with a crystal clear sealing tape and incubated at 5 ˚C, 23 ˚C and 37 ˚C.
Fluorescence measurements were carried out at regular intervals for 31 days as described
below.
For turbidity measurement, 100 μL of the above filtered samples were quickly transferred
to a 96-well crystal-clear microtiter plates in triplicate and the final volume was made up
to 200 μL using 50 mM sodium phosphate, pH 7.4. For monitoring aggregation under
different temperature conditions, all the samples were prepared in three separate plates.
The plates were sealed with a crystal clear sealing tape and incubated at 5 ˚C, 23 ˚C and
37 ˚C. Measurements were carried out as described below.
To determine the chemical stability, 1 mL of the above filtered samples were transferred
to 2 mL glass vials which were stored at three temperatures (5 ˚C, 23 ˚C and 37 ˚C).
5.2.7

Satibility study (35 days)

Phospho-Thr5- and phospho-Ser8-glucagon were prepared at 1 mg/mL in 50 mM sodium
phosphate, pH 7.4 and 1 mg/mL in 50 mM sodium phosphate with 10-4 M EDTA, pH 7.4.
Both with EDTA and without EDTA samples were centrifuged at 14,000 rpm for 5 min
and filtered through 0.1 μm filters to remove any insoluble material. The samples were
aliquoted to vials and sealed under nitrogen gas and stored away from light in room
temperature. At regulars intervals, sample vials were taken out to for the measurements
described below. Used sample vials were then discarded.
For fluorescence measurements, 100 μL of the filtered samples were quickly transferred
to a 96-well black flat bottom microtiter plate in triplicate and incubated with 50 μM ThT
final concentration. The final volume was adjusted to 200 μL using 50 mM sodium
phosphate, pH 7.4. Plates were also prepared at half of this concentration by transferring
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50 μL of the filtered samples microtiter plate and following the same procedure as above.
The plates were sealed with a crystal clear sealing tape. Fluorescence measurements were
performed as described below.
Same vials were used for turbidity measurement. 100 μL samples were quickly
transferred to a 96-well crystal-clear microtiter plates in triplicate and the final volume
was made up to 200 μL using 50 mM sodium phosphate, pH 7.4. Measurements were
carried out as described below.
5.2.8

ThT fluorescence measurements

Fibrillation was followed by measuring the fluorescence intensity of ThT with the
excitation and emission wavelengths set to 440 nm and 482 nm, respectively. For the 24hour studies, measurements were carried out at 15-min intervals for 24 h at 23°C with 5 s
automixing before each reading. For the initial 31 day studies, measurements were
carried out every other day for 31 days with 5 s automixing before each reading. For the
second 35 days studies measurements were carried out every week for 31 days with 5 s
automixing before each reading. Fluorescence signals of over 100,000 (overflow) were
set to 100,000 for visualization purposes.
5.2.9

Intrinsic fluorescence measurements

The excitation and emission wavelengths were set to 295 nm and 355 nm, respectively,
corresponding to the fluorescence of Trp25. For the 24-hour study, measurement was
carried out for 24 h at 23°C at 15-min intervals preceded by 5 s automixing before each
reading. For the initial 31 day study, measurement was carried out every other day for 31
days preceded by 5 s automixing before each reading. For the second 35 day study,
measurement was carried out every week for 35 days preceded by 5 s automixing before
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each reading. Very high fluorescence signals of over 100,000 (overflow) were set to
100,000 for visualization purposes.
5.2.10 Turbidity measurements
The turbidity of the peptide solutions was measured by UV absorbance at 405 nm
and 340 nm using a BioTek Synergy 4 Multi-Detection microplate reader (BioTek
Instruments, Winooski, VT). UV absorbance at 280 nm and 450 nm (Eq.14) and UV
absorbance at 280 nm and 450 nm (Eq.15) were used to calculate the aggregation index-1
(AI1) and aggregation index-2 (AI2) respectively. Measurement was carried out every
other day for initial 31 day stability study and every week for the second 35 stability study
preceded by 5 s automixing before each reading. The aggregation index was calculated
using Eq. 14 and/or Eq. 15.

𝐴𝐼1 = 100 × (

𝐴𝐼2 = 100 × (

𝐴𝑏𝑠 450𝑛𝑚
𝐴𝑏𝑠 280𝑛𝑚 − 𝐴𝑏𝑠 450𝑛𝑚
𝐴𝑏𝑠 340𝑛𝑚
𝐴𝑏𝑠 280𝑛𝑚 − 𝐴𝑏𝑠 340𝑛𝑚

)

)

Eq. 14
Eq. 15
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Figure 27: Possible conformations for glucagon fibril according to SAXS and
FTIR data. A and B show the two classes of possible formations. Each of these
classes can form the steric zipper also on the other side of the sheet resulting in
formations shown in C and D.
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Figure 28: All formations of glucagon steric zipper modelled by FibPredictor. The black
blocks show the sequence engaged in the steric zipper.
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5.3
5.3.1

Results

Computational analysis

An example of an energetically favorable model of the steric zipper of glucagon fibril is
in shown in Figure 29A. The model shown has the lowest average energy per residue
among all models. The top 10 most frequent inter-residue contacts in the top 500 most
energetically favorable models of the steric zipper region of the glucagon fibril are shown
in Table 8. The top three most frequent contacts, Trp25-Phe6, Val23-Phe6 and Trp25Gly4 are of hydrophobic nature. In addition, hydrophobic residues such as Phe6, Val23
and Trp25 are involved in seven out of the ten most frequent contacts, which confirms the
importance of hydrophobic interactions within the steric zipper. It is also observed that
four residues (Ser2, Thr5, Ser8 and Tyr10) which are involved in the top-10 most
frequent contacts can be phosphorylated. Based on this contact analysis, out hypothesis
was that the addition of a phosphate group on these four residues will insert a charged
and highly hydrophilic group into the core of a highly hydrophobic steric zipper, thus
“opening” the zipper and inhibiting fibril formation. Moreover, the charged phosphate
groups are expected to increase the solubility of the peptide.
5.3.2

MD Simulations of the Steric Zipper Model with and without Phosphorylation

Figure 30 shows the percentage of the initial contacts lost over the course of the
simulation of a model of the steric zipper (NOP) and its doubly protonated (SEN), singly
protonated (S1P) and doubly charged (SEP) phosphorylated analogues. FibPredictor is
designed to generate energetically favorable steric zippers and therefore, native contacts
are supposed to contribute to fibril formation. Loss of initial contact therefore, suggest a
potential instability of the steric zipper. NOP loses less than 10% of its initial contacts
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over the course of simulation and the steric zipper maintains its original formation. SEN
and S1P, which reproduce different protonation species of the phosphorylated analogues
in pH 2.5, lose around 10% and 15% of initial contacts. It should be noted that according
to the pKa of phosphoserine93the dominant species in pH=2.5 is the doubly protonated
analogue and therefore, the steric zipper of phosphorylated analogues at this pH is nearly
as stable as native glucagon. This observation is in line of fibril formation of phos-Ser8glucagon in pH=2.5. Nevertheless, SEP in pH=7.4 loses over 20% of its initial contacts
suggesting that the steric zipper is less stable at this pH value. This observation is in
agreement with the experimental results showing no fibrillation for phos-Ser8-glucagon
at pH=7.5.
5.3.3

Solubility

While glucagon is not soluble in pH 7.4, two of the glucagon derivatives, phospho-Thr5and phospho-Ser8-glucagon are soluble (10 mg/ml and 8 mg/ml respectively) in neutral
pH (Table 9). The solubility values presented here are according to reports by GenScript.
More accurate solubility measurements are underway in Dr. Elizabeth Topp’s lab.
5.3.4

Fluorescence measurements over 24 hours

Fluorescence measurements over 24 hours are shown in Figure 31A-D. Interaction of
ThT with amyloid β-fibrils results in an increase in the ThT fluorescence signal and
allows amyloid β-fibril formation to be probed. In pH 2.5 (Figure 31A), native glucagon
begins to fibrillate after a lag time of approximately 8 hours. Glucagon rapidly goes to
complete fibrillation after this lag time and the ThT signal reaches a plateau after
approximately 16 hours. The phosphorylated prodrugs also fibrillate at this pH but with a
longer lag time of approximately 15 hours. However, at pH 7.4 (Figure 31B) phospho-
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Thr5- and phospho-Ser8-glucagon show no fibrillation over 24 hours and the ThT signal
remains low for the period of study. Native glucagon and phospho-Ser2-glucagon cannot
be tested for fibrillation at pH 7.4 since they are not soluble at this pH. This demonstrates
that while glucagon and the phosphorylated prodrugs studied fibrillate under acidic
conditions, phospho-Thr-5- and phospho-Ser8-glucagon do not fibrillate in neutral pH
over 24-hours. A decrease in the Trp intrinsic fluorescence signal indicates
oligomerization of the peptide. In pH 2.5 (Figure 31C), glucagon intrinsic fluorescence
shows a sudden decrease after a lag time of nearly 9 hours. Similar behavior is observed
for phospho-glucagon prodrugs at pH 2.5, but with longer lag times of approximately 18
hours (phospho-Ser8-glucagon) and 21 hours (phospho-Ser2- and phospho-Thr5glucagon). Nonetheless, at 7.4 (Figure 31D) phospho-Ser8- and phospho-Thr5-glucagon
intrinsic fluorescence signals remain high with no decreasing trend, which indicates a
lack of oligomerization for these peptides at pH 7.4.
5.3.5

ThT fluorescence measurements over the initial 31-day stability study

Figure. 32A-C show the results for ThT assays for 31 days. As mentioned above, upon
interaction of ThT with amyloid fibrils, the ThT fluorescence signal increases and allows
identification of amyloid fibril formation. The ThT fluorescence remained low for
samples stored at 5˚C (Figure 32A), 23˚C (Figure 32B) and 37˚C (Figure 32C) for 31
days. This indicates lack of fibrillation in these samples over the extended time period
and the three temperatures studied.
5.3.6

ThT fluorescence measurements over the 35-day stability study

Figure 33 shows the results for ThT assays for 35 days. As mentioned above, upon
interaction of ThT with amyloid fibrils, the ThT fluorescence signal increases and allows
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identification of amyloid fibril formation. The ThT fluorescence remained low for
samples stored with and without EDTA for 35 days. This indicates lack of fibrillation in
these samples over the extended time period and the three temperatures studied.
5.3.7

Intrinsic fluorescence measurement over the initial 31-day stability study

Figure 34A-C show results from Trp intrinsic fluorescence measurements over 31 days.
A decrease in the Trp intrinsic fluorescence signal indicates oligomerization of the
peptide. No such decrease was observed in the Trp fluorescence signal for samples stored
at 5˚C (FIG. 4A), 23˚C (FIG. 4B) and 37˚C (FIG. 4C) for 31 days. This indicates no
oligomerization at any of the incubation temperatures over 31 days.
5.3.8

Intrinsic fluorescence measurement over the 35-day stability study

Figure 35A-C show results from Trp intrinsic fluorescence measurements over 35 days.
A decrease in the Trp intrinsic fluorescence signal indicates oligomerization of the
peptide. No such decrease was observed in the Trp fluorescence signal for samples stored
with or without EDTA for 35 days. This indicates no oligomerization over 35 days in
either of the formulations.
5.3.9

Turbidity measurement over the initial 31-day stability study

Figure 36A-C show the results of aggregation index measurements over 31 days. Proteins
do not absorb UV light at 450 nm. Any absorbance observed in this wavelength is
generally due the light scattering by particles resulting from aggregation, and the
aggregation index-1 (AI-1) helps quantify this. AI-1 values remained below 5 for samples
stored at 5˚C (Figure 36A), 23˚C (Figure 36B) and 37˚C (Figure 36C) for 31 days. This
indicates that no significant turbidity was observed for either of the two phosphoglucagon peptides at any of the incubation temperatures.
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5.3.10 Turbidity measurement over the 35-day stability study
Figures. 37 and 38 shows the results of AI-1 and AI-2 respectively over 35 days. Proteins
do not absorb UV light at 450 nm and 340 nm. Any absorbance observed in these
wavelength is generally due the light scattering by particles resulting from aggregation,
and the aggregation indices (AI-1 and AI-2) helps quantify this. AI values remained
below 5% for samples stored with or without EDTA for 35 days. This indicates that no
significant turbidity was observed for either of the two phospho-glucagon peptides in any
of the two formulations.
5.3.11 Visual Inspection of Vials in the Second Stability Study
FIGs 10A-D show photographs of sample of the second stability study up to 28 days. No
turbidity or visible particles were observed in the vials of phospho-Ser8-Glucagon and
phospho-Thr5-Glucagon with or without EDTA.
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Figure 29: A) An example of energetically favorable steric zipper models
generated by FibPredictor. B) Same model phosphorylated at Ser-8.
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Figure 30: percentage of the native contacts lost over the course of the simulation of a
model of steric zipper (NOP) and its doubly protonated (SEN), singly protonated (S1P)
and doubly charged (SEP) phosphorylated analogues in different pH conditions
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Figure 32: ThT assay of the initial 31-day stability study in A) 5 ͦC, B) 23 ͦC and C) 37 ͦC
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Figure 33: ThT assay of the 35-day stability study
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Figure 34: Intrinsic fluorescence assay of the initial 31-day stability study in A) 5 ͦC, B)
23 ͦC and C) 37 ͦC.

Fluorescence

145

phospho-Ser8-Glucagon

phospho-Ser8-Glucagon+EDTA

phospho-Thr5-Glucagon

phospho-Thr5-Glucagon+EDTA

90000
80000
70000
60000
50000
40000
30000
20000
10000
0
day 14

day 21

day 28

day 35

Figure 35: Intrinsic fluorescence assay of the 35-day stability study
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Figure 36: Aggregation index over 31-day initial stability study study in A) 5 ͦC, B) 23 ͦC
and C) 37 ͦC.
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Figure 37: Aggregation index-1 over 35 days
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Figure 39: photographs of sample of the second stability study on day A) 7, B) 14, C)
21 and D) 28 and E) 35. Samples remain clear with no visible particle.
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5.4

Discussions

Computational modelling of the glucagon fibril steric zipper suggests that
phosphorylation on Ser8 and Thr5 can effectively inhibit fibrillation by introducing an
anionic charged group into the hydrophobic entanglements of sidechains between the two
β-sheets. This computational prediction is verified by experiments that show phosphoSer8- and phospho-Thr5-glucagon are soluble and stable. Neither phospho-Thr5Glucagon nor phospho-Ser8-Glucagon shows fibrillation and neutral pH solution of both
remain clear with no turbidity for more than one month. This indicates the potential of
these molecules to be formulated as injection pen or for use in artificial pancreas devices.
The fact that phospho-Ser2-glucagon fibrillates in both acidic and neutral pH shows that
phosphorylation inhibits fibrillation in a site-specific way and merely hanging a charged
group on glucagon is not enough for preventing its fibrillation. The charged group should
be placed on the correct residue.
Phosphate derivatization increases the net charge of glucagon and, consequently,
increases the solubility of glucagon at neutral pH. As a result, while glucagon is not
soluble at neutral pH and should be solubilized in acidic pH, all three of the
phosphorylated glucagon analogues tested in this study are soluble at both acidic and
neutral pH.
ThT assays and intrinsic fluorescence assays over 24 hours show that phospho-Thr5Glucagon and phospho-Ser8-Glucagon are both stable and do not fibrillation at pH 7.4.
Both of these molecules, however, fibrillate at pH 2.5. This observation can be explained
by different charge states of the phosphate group in the acidic and neutral pH. MD
simulations of glucagon and its phosphorylated analogues in different pHs confirm and
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clarify the effect of the charge state of the phosphate group on its fibrillation inhibition
effects. MD simulations show that the steric zipper of phospho- glucagon is stable in
absence of the phosphate group, and in singly and doubly protonated states in neutral pH
simulations. The steric zipper, however, does not remain stable in acidic pH simulations
where the phosphate group is not protonated and is doubly charged. The steric effect of
the additional volume introduced by the phosphate group therefore, is not enough to
destabilize the steric zipper and the electric charge of the phosphate moieties plays an
important role in their fibrillation inhibition effects.

5.5

Conclusions

In this study phosphate-ester derivatives of glucagon were computationally designed and
tested as soluble and stable prodrugs or active derivatives of glucagon. The
phosphorylated glucagons showed significantly improved solubility in neutral pH
compared to glucagon. Also, contrary to glucagon which fibrillates in few hours, the
phosphorylated glucagons did not fibrillate and were stable for weeks.
Our research group has applied for a patent on all phosphate ester derivatives of glucagon
(patent application number 62/195,537).
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Table 8: The 10 most frequent inter-residue contacts in the 500 most energetically
favorable models of the steric zipper region of glucagon fibril.
Contact

Frequency

Trp25-Phe6

327

Val23-Phe6

256

Trp25-Gly4

249

Trp25-Thr5

206

Met27-Ser2

183

Asp21-Tyr10

183

Trp25-Gln3

159

Val23-Ser8

158

Gln24-Phe6

145

Asp21-Ser8

142
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Table 9: Solubility in neutral pH
Peptide

pH 7.4 (PBS)

Glucagon

Not Soluble

phospho-Ser2-Gluc.

Not Soluble

phospho-Thr5-Gluc.

8 mg/ml

phospho-Ser8-Gluc.

10 mg/ml
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CHAPTER 6. CONCLUSIONS

Two strategies were tested for stabilization of glucagon formulation and preventing its
fibrillation, penta-peptide chaperon excipients and derivatization of glucagon itself.
Penta-peptides were shown to delay glucagon fibrillation for a few hundred minutes.
However, after this lag time, glucagon entered a log phase and fibrillated rapidly. This
delay, therefore, was not enough for stable formulation of glucagon.
Derivatization of glucagon was shown to be more effective for inhibiting glucagon
fibrillation. Two phosphate ester derivatives of glucagon, phospho-Ser8- and phosphoThr5-glucagon designed in this study, were stable and stayed in solution at neutral pH for
at least one month. Currently dephosphorization studies, chemical stability studies, cellbased assays and animal studies are underway to test the activity of these molecules and
their mechanism of actions and find ways to further improve their formulation.
The phosphate ester derivatives of glucagon were designed based on a computational
method (FibPredictor) developed as a part of this project to model the steric zipper of
amyloid fibrils. This computational method is not limited to a specific protein and can be
applied to generate models of steric zippers starting from any user-defined sequence. The
generated models can be used in combination with experimental data or as input for
further computational studies. This computational method is now publicly available on
anoHub.org.

156
Another developments in this dissertation, were a number of quasi-three body statistical
potentials for protein structure predictions. The most successful of these potentials (Amb3b) has been implemented in FibPredictor. However, the application of these potentials is
not limited to fibrils and they can be broadly used for any type of protein structure
prediction. Moreover, the theoretical framework of these quasi-three body potentials can
be further expanded for information-theoric studies on protein structure94.
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